Matthew Cooperberg, MD, MPH
Professor
Urology
School of Medicine

Both clinician and patient decisions influence the choices about the type of treatment a patient will receive for localized prostate and kidney (renal) cancer. Matthew Cooperberg, MD, MPH is conducting an ongoing research program to study national prostate cancer management trends, based on data from CaPSURE and other sources. His analyses have looked at changes in cancer risk over time, testing and treatment for prostate cancer, local variation in treatment, and the impact of socio-demographic factors on type of treatment and outcomes. Through the creation of a San Francisco General Hospital (SFGH) prostate cancer patient registry, preliminary analysis show that low socioeconomic status patients are treated for a higher percentage of high-risk disease than patients with a higher socioeconomic status. Using data from CaPSURE, the NCDB, SFGH and in collaboration with the Urologic Diseases in America project he continues to explore these topic in depth.

Prostate Cancer Risk Assessment and Comparative Effectiveness Research

Properly treating prostate cancer requires determining how likely is it that the cancer will progress. Cooperberg led the team that developed the UCSF-CAPRA score, a prostate cancer risk assessment tool that has been validated in several multi-institutional studies in the U.S. and Europe. CAPRA predicts biochemical recurrence-free survival (PSA level does not rise) after radical prostatectomy with an accuracy at least as good as more mathematically complex nomograms that require complex tables or computer software to calculate and other risk assessment instruments. The score is easy to calculate, and can be used to predict an individual's likelihood of metastasis, cancer-specific mortality, and overall mortality after treatment by surgery, radiation therapy, or androgen deprivation therapy.

Cooperberg is currently developing a post-operative extension of the CAPRA score (CAPRA-S). After surgery additional information is available from the pathologist's analysis of the removed prostate. This information can help identify men who will benefit from additional therapy such as radiation and/or hormonal therapy after surgery. CAPRA-S will help in that decision making process. Cooperberg is also collaborating with a group of Japanese scientist to develop a prediction instrument specifically applicable to high-risk patients and patients receiving androgen deprivation therapy (J-CAPRA). As new biomarkers, such as genomic and advanced imaging data, are proven valid by UCSF Urology and collaborating laboratory investigators, Cooperberg plans to integrate the information into the current standard measures of risk and outcomes to improve risk assessment. These findings will help men determine with greater confidence whether active surveillance, surgery, radiation, hormonal therapy, or some combination may be most appropriate for them.

Because accurate risk assessment is essential to compare the effectiveness of different prostate cancer treatments, Cooperberg is currently conducting such comparison studies using CaPSURE data. These data will provide a unique source of insight for future comparative effectiveness research.

Survivorship

Cooperberg is collaborating on a project that will lead to better clinical care for cancer survivors. His efforts have helped to develop UCSF’s Urologic Oncology Database (UODB) into a comprehensive data repository for clinical information about patients treated for prostate, bladder, and renal cancers. With the Urology Department’s information experts Cooperberg is developing an automated process to further augment UODB by automatically transferring data from the UCSF Medical Center’s information system into UODB. In collaboration with UCSF Breast Oncology and a health care web services company Cooperberg is developing an electronic survey for cancer patients. Patients will complete a health history and health-related quality of life (HRQOL) survey prior to their first visit to the clinic and at defined intervals after treatment. This effort is expected to help patients and clinicians track HRQOL outcomes, such as urinary and sexual function, after treatment. The survey will help physicians to identify those patients who may need to be seen in clinic more or less frequently.

Small Renal Masses

In collaboration with the laboratory of John Kurhanewicz, PhD, Cooperberg is conducting a study to see if magnetic resonance spectroscopy (MRS) can be used to non-invasively diagnosis small renal tumors. MRS is a specialized technique associated with magnetic resonance imaging (MRI). MRS equipment can be used to pick up signals from different chemical nuclei within the body. A preliminary laboratory study is using tissue to identify the specific MRS signals associated with a variety of renal tumors. Once renal tumor signals have been identified, Cooperberg plans to test the ability of MRS to accurately analyze renal tumors in patients. This will be done by using MRS imaging technology on patients who are already scheduled for renal cancer surgery prior to their operation. The pre and post surgery information can be analyzed to determine if the information collected non-invasively by the MRS technology matches the histology and grade of the actual tumor.

• Initial Experience with 68Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2024 Koshkin VS, Kumar V, Kline B, Escobar D, Aslam M, Cooperberg MR, Aggarwal RR, de Kouchkovsky I, Chou J, Meng MV, Friedlander T, Porten S, Hope TA
• The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancer.
  Cancer 2024 Braun AE, Chan JM, Neuhaus J, Cowan JE, Kenfield SA, Van Blarigan EL, Tenggara I, Broering JM, Simko JP, Carroll PR, Cooperberg MR
• Amount of Gleason Pattern 3 Is Not Predictive of Risk in Grade Group 2-4 Prostate Cancer.
  European urology 2024 Vickers AJ, Assel M, Cooperberg MR, Fine SW, Eggener S
• Can early prostate cancer screening help address mortality disparities among Black men?
  Journal of the National Cancer Institute 2024 Cooperberg MR
• Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative study.
  BMC cancer 2023 Guan A, Santiago-Rodríguez EJ, Chung BI, Shim JK, Allen L, Kuo MC, Lau K, Loya Z, Brooks JD, Cheng I, DeRouen MC, Frosch DL, Golden T, Leppert JT, Lichtensztajn DY, Lu Q, Oh D, Sieh W, Wadhwa M, …
• The Impact of Delayed Radical Prostatectomy on Recurrence Outcomes After Initial Active Surveillance: Results from a Large Institutional Cohort.
  European urology oncology 2023 Shee K, Cowan JE, Washington SL, Shinohara K, Nguyen HG, Cooperberg MR, Carroll PR
• Correction to: Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer.
  Prostate cancer and prostatic diseases 2023 Tallman JE, Wallis CJD, Zhao Z, Huang LC, Penson DF, Koyama T, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Hoffman KE, Barocas DA
• How older men live with stress urinary incontinence: Patient experience and navigation to treatment.
  Neurourology and urodynamics 2023 Shaw NM, Breyer BN, Walter LC, Sudore RL, Suskind AM, Baussan C, Quanstrom K, Allen IE, Cooperberg MR, Dohan D, Hampson LA
• The influence of the "cancer" label on perceptions and management decisions for low-grade prostate cancer.
  Journal of the National Cancer Institute 2023 Berlin A, Ramotar M, Santiago AT, Liu Z, Li J, Wolinsky H, Wallis CJD, Chua MLK, Paner GP, van der Kwast T, Cooperberg MR, Vickers AJ, Urbach DR, Eggener SE
• Prostate cancer risk stratification using magnetic resonance imaging-ultrasound fusion vs systematic prostate biopsy.
  JNCI cancer spectrum 2023 Khajir G, Press B, Lokeshwar S, Ghabili K, Rahman S, Gardezi M, Washington S, Cooperberg MR, Sprenkle P, Leapman MS
• Effect of a Home-based Walking Intervention on Cardiopulmonary Fitness and Quality of Life Among Men with Prostate Cancer on Active Surveillance: The Active Surveillance Exercise Randomized Controlled Trial.
  European urology oncology 2023 Van Blarigan EL, Kenfield SA, Olshen A, Panchal N, Encabo K, Tenggara I, Graff RE, Bang AS, Shinohara K, Cooperberg MR, Carroll PR, Jones LW, Winters-Stone K, Luke A, Chan JM
• Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer.
  European urology 2023 Herlemann A, Cowan JE, Washington SL, Wong AC, Broering JM, Carroll PR, Cooperberg MR
• Ten-year work burden after prostate cancer treatment.
  Cancer medicine 2023 Washington SL, Lonergan PE, Cowan JE, Zhao S, Broering JM, Palmer NR, Hicks C, Cooperberg MR, Carroll PR
• Diabetes and Prostate Cancer Outcomes in Men with Nonmetastatic Castration-Resistant Prostate Cancer: Results from the SEARCH Cohort.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2023 Sergeyev A, Gu L, De Hoedt AM, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Klaassen Z, Terris MK, Guerrios-Rivera L, Freedland SJ, Csizmadi I
• Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer.
  BJUI compass 2023 Leapman MS, Sutherland R, Gross CP, Ma X, Seibert TM, Cooperberg MR, Catalona WJ, Loeb S, Schulman-Green D
• The state of focal therapy in the treatment of prostate cancer: the university of California collaborative (UC-Squared) consensus statement.
  Prostate cancer and prostatic diseases 2023 Javier-DesLoges J, Dall'Era MA, Brisbane W, Chamie K, Washington SL, Chandrasekar T, Marks LS, Nguyen H, Daneshvar M, Gin G, Kane CJ, Bagrodia A, Cooperberg MR
• Club-like cells in proliferative inflammatory atrophy of the prostate.
  The Journal of pathology 2023 Huang FW, Song H, Weinstein HN, Xie J, Cooperberg MR, Hicks J, Mummert L, De Marzo AM, Sfanos KS
• Multi-institutional Development and External Validation of a Machine Learning Model for the Prediction of Distant Metastasis in Patients Treated by Salvage Radiotherapy for Biochemical Failure After Radical Prostatectomy.
  European urology focus 2023 Sabbagh A, Tilki D, Feng J, Huland H, Graefen M, Wiegel T, Böhmer D, Hong JC, Valdes G, Cowan JE, Cooperberg M, Feng FY, Mohammad T, Shelan M, D'Amico AV, Carroll PR, Mohamad O
• Presurgical 68Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial.
  European urology 2023 Djaïleb L, Armstrong WR, Thompson D, Gafita A, Farolfi A, Rajagopal A, Grogan TR, Nguyen K, Benz MR, Hotta M, Barbato F, Ceci F, Schwarzenböck SM, Unterrainer M, Zacho HD, Juarez R, Cooperberg M, …
• Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer Subtypes.
  European urology oncology 2023 Chappidi MR, Sjöström M, Greenland NY, Cowan JE, Baskin AS, Shee K, Simko JP, Chan E, Stohr BA, Washington SL, Nguyen HG, Quigley DA, Davicioni E, Feng FY, Carroll PR, Cooperberg MR
• Explainable ML models for a deeper insight on treatment decision for localized prostate cancer.
  Scientific reports 2023 Han JH, Lee S, Lee B, Baek OK, Washington SL, Herlemann A, Lonergan PE, Carroll PR, Jeong CW, Cooperberg MR
• Are associations between obesity and prostate cancer outcomes following radical prostatectomy the same in smokers and non-smokers? Results from the SEARCH Cohort.
  Cancer causes & control : CCC 2023 Liu IT, Gu L, De Hoedt AM, Cooperberg MR, Amling CL, Kane CJ, Klaassen Z, Terris MK, Guerrios-Rivera L, Vidal AC, Aronson WJ, Freedland SJ, Csizmadi I
• Long-term complications and health-related quality of life outcomes after radical prostatectomy with or without subsequent radiation treatment for prostate cancer.
  Urologic oncology 2023 Baskin A, Cowan JE, Braun A, Lonergan PE, Mohamad O, Washington SL, Zhao S, Broering JM, Cooperberg MR, Breyer BN, Carroll PR
• Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 Patel P, Harmon S, Iseman R, Ludkowski O, Auman H, Hawley S, Newcomb LF, Lin DW, Nelson PS, Feng Z, Boyer HD, Tretiakova MS, True LD, Vakar-Lopez F, Carroll PR, Cooperberg MR, Chan E, Simko J, Fazli L…
• Prostate Cancer in Transgender Women in the Veterans Affairs Health System, 2000-2022.
  JAMA 2023 Nik-Ahd F, De Hoedt A, Butler C, Anger JT, Carroll PR, Cooperberg MR, Freedland SJ
• Prostate cancer is not just a man's concern - the use of PSA screening in transgender women.
  Nature reviews. Urology 2023 Nik-Ahd F, Anger JT, Cooperberg MR, Freedland SJ
• The Long-term Incidence and Quality of Life Outcomes Associated With Treatment-Related Toxicities of External Beam Radiotherapy for Prostate Cancer.
  Urology 2023 Lonergan PE, Baskin A, Greenberg SA, Mohamad O, Washington SL, Zhao S, Cowan JE, Broering JM, Nguyen HG, Cooperberg MR, Breyer BN, Carroll PR
• Re: Fifteen-year Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
  European urology 2023 Cooperberg MR
• Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate Cancer.
  European urology open science 2023 Fallara G, Robesti D, Raggi D, Montorsi F, Necchi A, Cooperberg MR, Malavaud B, Ploussard G, Martini A
• Physician Perception of Grade Group 1 Prostate Cancer.
  European urology focus 2023 Saoud R, Woranisarakul V, Paner GP, Ramotar M, Berlin A, Cooperberg M, Eggener SE
• Stability of Prognostic Estimation Using the CAPRA Score Incorporating Imaging-based vs Physical Exam-based Staging.
  The Journal of urology 2023 Chang K, Greenberg SA, Cowan JE, Parker R, Shee K, Washington SL, Nguyen HG, Shinohara K, Carroll PR, Cooperberg MR
• Time from biopsy to radical prostatectomy by race in an equal-access healthcare system: Results from the SEARCH cohort.
  The Prostate 2023 Pereira V, Oyekunle T, Janes J, Amling CJ, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Klaassen Z, Freedland SJ, Vidal AC, Csizmadi I
• PSA density does not improve predictive accuracy of the UCSF-CAPRA score.
  The Prostate 2023 Parker R, Bell A, Chang K, Greenberg S, Washington SL, Cowan JE, Carroll PR, Cooperberg MR
• Patient-identified Treatment Attributes Among Older Men With Stress Urinary Incontinence: A Qualitative Look at What Matters to Patients Making Treatment Decisions.
  Urology 2023 Hampson LA, Shaw NM, Breyer BN, Walter LC, Sudore RL, Cooperberg MR, Baussan C, Quanstrom K, Elaine Allen I, Dohan D
• Prostate cancer disparities among American Indians and Alaskan Natives in the United States.
  Journal of the National Cancer Institute 2023 Chu CE, Leapman MS, Zhao S, Cowan JE, Washington SL, Cooperberg MR
• A modeling study to estimate prostate cancer-specific mortality on active surveillance for men with favorable intermediate-risk prostate cancer: Results from the SEARCH cohort.
  Cancer medicine 2023 Kuhlmann PK, Oyekunle T, Klaassen Z, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Freedland SJ
• Reply to X. Farré et al.
  JCO global oncology 2023 Vickers A, Berlin A, Paner G, Cooperberg M, Wolinsky H, Eggener S
• Seeing the unseen: how can we best identify transgender women within the Veterans Affairs healthcare system's electronic medical record?
  The journal of sexual medicine 2023 Nik-Ahd F, Waller J, De Hoedt AM, Garcia MM, Figueiredo JC, Carroll PR, Cooperberg MR, Freedland SJ
• Patient decision-making for surgical treatment of post-prostatectomy stress urinary incontinence: a mixed-methods exploratory pilot study.
  Translational andrology and urology 2023 Shaw NM, Nik-Ahd F, Jones C, Breyer BN, Walter LC, Sudore R, Cooperberg MR, Baussan C, Quanstrom K, Allen IE, Hampson LA
• Observation, Radiotherapy, or Radical Prostatectomy for Localized Prostate Cancer: Survival Analysis in the United States.
  The world journal of men's health 2023 Han JH, Herlemann A, Washington SL, Lonergan PE, Carroll PR, Cooperberg MR, Jeong CW
• Limited Relevance of the Very Low Risk Prostate Cancer Classification in the Modern Era: Results from a Large Institutional Active Surveillance Cohort.
  European urology 2023 Shee K, Cowan JE, Balakrishnan A, Escobar D, Chang K, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR
• A vision for closing the evidence-practice gap in the management of low-grade prostate cancer.
  JNCI cancer spectrum 2023 Leapman MS, Loeb S, Cooperberg MR, Catalona WJ, Gaylis FD
• Correction to: Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer.
  Prostate cancer and prostatic diseases 2023 Tallman JE, Wallis CJD, Huang LC, Zhao Z, Penson DF, Koyama T, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Barocas DA,…
• Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer.
  European urology oncology 2023 Sabbagh A, Washington SL, Tilki D, Hong JC, Feng J, Valdes G, Chen MH, Wu J, Huland H, Graefen M, Wiegel T, Böhmer D, Cowan JE, Cooperberg M, Feng FY, Roach M, Trock BJ, Partin AW, D'Amico AV, Carroll…
• Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US.
  JAMA network open 2023 Cooperberg MR, Meeks W, Fang R, Gaylis FD, Catalona WJ, Makarov DV
• The natural history of a delayed detectable PSA after radical prostatectomy.
  Prostate cancer and prostatic diseases 2023 Szymaniak JA, Washington SL, Cowan JE, Cooperberg MR, Lonergan PE, Nguyen HG, Meng MV, Carroll PR
• Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation.
  The Journal of urology 2023 Leapman MS, Wang R, Loeb S, Seibert TM, Gaylis FD, Lowentritt B, Brown GA, Chen R, Lin D, Witte J, Cooperberg MR, Catalona WJ, Gross CP, Ma X
• Active Surveillance in Michigan: What Is Possible When Payers Partner with Physicians.
  European urology 2023 Cooperberg MR
• Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting.
  European urology oncology 2023 Moore CM, King LE, Withington J, Amin MB, Andrews M, Briers E, Chen RC, Chinegwundoh FI, Cooperberg MR, Crowe J, Finelli A, Fitch MI, Frydenberg M, Giganti F, Haider MA, Freeman J, Gallo J, Gibbs S, …
• Insights from the AQUA Registry: a retrospective study of anticholinergic polypharmacy in the United States.
  Therapeutic advances in urology 2023 Cooperberg MR, Mbassa R, Walker D, Meeks W, Lockefeer A, Jiang B, Li T, Johnston K, Fang R
• Reply to Sandra Patricia García Nader, Sebastián Peña Rodríguez, and Cesar Alejandro Diaz Ritter's Letter to the Editor re: Farnoosh Nik-Ahd, Andrew Jarjour, Jane Figueiredo, et al. Prostate-specific Antigen Screening in Transgender Patients. Eur Urol. 2023;83:48-54.
  European urology 2023 Nik-Ahd F, Cooperberg MR, Freedland SJ
• Protocol for a 4-arm randomized controlled trial testing remotely delivered exercise-only, diet-only, and exercise + diet interventions among men with prostate cancer treated with radical prostatectomy (Prostate 8-II).
  Contemporary clinical trials 2023 Van Blarigan EL, Chan JM, Sanchez A, Zhang L, Winters-Stone K, Liu V, Macaire G, Panchal N, Graff RE, Tenggara I, Luke A, Simko JP, Cooperberg MR, Carroll PR, Kenfield SA
• Antiandrogen Treatment vs Active Surveillance for Patients With Prostate Cancer-Reply.
  JAMA oncology 2023 Shore ND, Cooperberg MR, Tomlins SA
• Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer.
  Prostate cancer and prostatic diseases 2022 Tallman JE, Wallis CJD, Zhao Z, Huang LC, Penson DF, Koyama T, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Hoffman KE, Barocas DA
• Reply to M. Baboudjian et al.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 Eggener SE, Berlin A, Vickers AJ, Paner GP, Wolinsky H, Cooperberg MR
• Reply by Authors.
  The Journal of urology 2022 De B, Pasalic D, Barocas DA, Wallis CJD, Huang LC, Zhao Z, Koyama T, Tang C, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Penson …
• Prostate-Specific Antigen Screening in Transgender Patients.
  European urology 2022 Nik-Ahd F, Jarjour A, Figueiredo J, Anger JT, Garcia M, Carroll PR, Cooperberg MR, Vidal AC, Freedland SJ
• Association between body mass index and localized prostate cancer management and disease-specific quality of life.
  BJUI compass 2022 Samora NL, Wallis CJD, Huang LC, Tallman JE, Zhao Z, Hoffman K, Morgans A, Cooperberg M, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan S, O'Neil B, Paddock LE, Stroup A, Wu XC, Koyama T, …
• The Association Between Financial Toxicity and Treatment Regret in Men With Localized Prostate Cancer.
  JNCI cancer spectrum 2022 Joyce DD, Wallis CJD, Huang LC, Hoffman KE, Zhao Z, Koyama T, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Penson DF, Barocas DA
• Emulation of a target trial with sustained treatment strategies: an application to prostate cancer using both inverse probability weighting and the g-formula.
  European journal of epidemiology 2022 Smith LH, García-Albéniz X, Chan JM, Zhao S, Cowan JE, Broering JM, Cooperberg MR, Carroll PR, Hernán MA
• Removing the Designation of Cancer from Grade Group 1 Disease Will Do More Good than Harm.
  European urology 2022 Vickers AJ, Cooperberg MR, Eggener SE
• Focal Therapy for Prostate Cancer: Evolutionary Parallels to Breast Cancer Treatment.
  The Journal of urology 2022 Labbate CV, Klotz L, Morrow M, Cooperberg M, Esserman L, Eggener SE
• Biomarkers in Urologic Oncology: So Much Progress, So Much Yet To Do.
  European urology focus 2022 Cooperberg MR
• Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort.
  The Journal of urology 2022 Shee K, Washington SL, Cowan JE, de la Calle CM, Baskin AS, Chappidi MR, Escobar D, Nguyen HG, Cooperberg MR, Carroll PR
• Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)?
  Prostate cancer and prostatic diseases 2022 Klaassen Z, Howard L, Wallis CJD, Janes JL, De Hoedt A, Aronson WJ, Polascik TJ, Amling CJ, Kane CJ, Cooperberg MR, Terris MK, Wu Y, Freedland SJ
• Patient-reported Outcomes After External Beam Radiotherapy With Low Dose Rate Brachytherapy Boost vs Radical Prostatectomy for Localized Prostate Cancer: Five-year Results From a Prospective Comparative Effectiveness Study.
  The Journal of urology 2022 De B, Pasalic D, Barocas DA, Wallis CJD, Huang LC, Zhao Z, Koyama T, Tang C, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Penson …
• Reply by Authors.
  Urology practice 2022 Taich L, Zhao H, Stock SR, Howard LE, De Hoedt AM, Terris MK, Amling CL, Kane CJ, Cooperberg MR, Aronson WJ, Klaassen Z, Polascik TJ, Vidal AC, Freedland SJ
• Blood Prostate-specific Antigen by Volume of Benign, Gleason Pattern 3 and 4 Prostate Tissue.
  Urology 2022 Andolfi C, Vickers AJ, Cooperberg MR, Carroll PR, Cowan JE, Paner GP, Helfand BT, Liauw SL, Eggener SE
• Improving multiparametric MR-transrectal ultrasound guided fusion prostate biopsies with hyperpolarized 13 C pyruvate metabolic imaging: A technical development study.
  Magnetic resonance in medicine 2022 Chen HY, Bok RA, Cooperberg MR, Nguyen HG, Shinohara K, Westphalen AC, Wang ZJ, Ohliger MA, Gebrezgiabhier D, Carvajal L, Gordon JW, Larson PEZ, Aggarwal R, Kurhanewicz J, Vigneron DB
• Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial.
  JAMA oncology 2022 Shore ND, Renzulli J, Fleshner NE, Hollowell CMP, Vourganti S, Silberstein J, Siddiqui R, Hairston J, Elsouda D, Russell D, Cooperberg MR, Tomlins SA
• Accommodating heterogeneous missing data patterns for prostate cancer risk prediction.
  BMC medical research methodology 2022 Neumair M, Kattan MW, Freedland SJ, Haese A, Guerrios-Rivera L, De Hoedt AM, Liss MA, Leach RJ, Boorjian SA, Cooperberg MR, Poyet C, Saba K, Herkommer K, Meissner VH, Vickers AJ, Ankerst DP
• Medium Term Outcomes of Focal Cryoablation for Intermediate and High Risk Prostate Cancer: MRI and PSA are Not Predictive of Residual or Recurrent Disease.
  Urologic oncology 2022 Baskin A, Charondo LB, Balakrishnan A, Cowan JE, Cooperberg MR, Carroll PR, Nguyen H, Shinohara K
• Radium-223 Utilization Patterns and Outcomes in Clinical Practice.
  Urology practice 2022 Taich L, Zhao H, Stock SR, Howard LE, De Hoedt AM, Terris MK, Amling CL, Kane CJ, Cooperberg MR, Aronson WJ, Klaassen Z, Polascik TJ, Vidal AC, Freedland SJ
• Validation of the prostate cancer comorbidity index in predicting cause-specific mortality in men undergoing radical prostatectomy.
  Prostate cancer and prostatic diseases 2022 Chen MS, Howard LE, Stock S, Dolgner A, Freedland SJ, Aronson W, Terris M, Klaassen Z, Kane C, Amling C, Cooperberg M, Daskivich TJ
• Low-Grade Prostate Cancer: Time to Stop Calling It Cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 Eggener SE, Berlin A, Vickers AJ, Paner GP, Wolinsky H, Cooperberg MR
• Reply to Benjamin Davies, Keith Kowalczyk RE: Zachary Klaassen, Emily Vertosick, Andrew J. Vickers, et al. Optimal Dissemination of Scientific Manuscripts via Social Media: A Prospective Trial Comparing Visual Abstracts Versus Key Figures in Consecutive Original Manuscripts. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.01.041.
  European urology 2022 Klaassen Z, Catto JWF, Vickers AJ, Cooperberg MR, Kutikov A
• Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care.
  European urology 2022 Nyame YA, Cooperberg MR, Cumberbatch MG, Eggener SE, Etzioni R, Gomez SL, Haiman C, Huang F, Lee CT, Litwin MS, Lyratzopoulos G, Mohler JL, Murphy AB, Pettaway C, Powell IJ, Sasieni P, Schaeffer EM, …
• Association between Treatment for Localized Prostate Cancer and Mental Health Outcomes.
  The Journal of urology 2022 Luckenbaugh AN, Wallis CJD, Huang LC, Wittmann D, Klaassen Z, Zhao Z, Koyama T, Laviana AA, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan …
• Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer.
  Prostate cancer and prostatic diseases 2022 Tallman JE, Wallis CJD, Huang LC, Zhao Z, Penson DF, Koyama T, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Barocas DA,…
• Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer.
  European urology open science 2022 Press BH, Jones T, Olawoyin O, Lokeshwar SD, Rahman SN, Khajir G, Lin DW, Cooperberg MR, Loeb S, Darst BF, Zheng Y, Chen RC, Witte JS, Seibert TM, Catalona WJ, Leapman MS, Sprenkle PC
• Conservative Management of Low-Risk Prostate Cancer: A Path to Value-Based Care.
  Urology practice 2022 Gaylis FD, Cooperberg MR, Loeb S, Chen RC, Seibert TM, Cohen E, Dato P, Emeka AA, Prime R, Romo S, Catalona WJ
• Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 Chan E, McKenney JK, Hawley S, Corrigan D, Auman H, Newcomb LF, Boyer HD, Carroll PR, Cooperberg MR, Klein E, Fazli L, Gleave ME, Hurtado-Coll A, Simko JP, Nelson PS, Thompson IM, Tretiakova MS, …
• Optimal Dissemination of Scientific Manuscripts via Social Media: A Prospective Trial Comparing Visual Abstracts Versus Key Figures in Consecutive Original Manuscripts Published in European Urology.
  European urology 2022 Klaassen Z, Vertosick E, Vickers AJ, Assel MJ, Novara G, Pierce C, Wallis CJD, Larcher A, Cooperberg MR, Catto JWF, Kutikov A
• Red Blood Cell Distribution Width Is Associated with All-cause Mortality but Not Adverse Cancer-specific Outcomes in Men with Clinically Localized Prostate Cancer Treated with Radical Prostatectomy: Findings Based on a Multicenter Shared Equal Access Regional Cancer Hospital Registry.
  European urology open science 2022 Orabi H, Howard L, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Klaassen Z, Janes JL, Freedland SJ, Polascik TJ
• Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states.
  Nature communications 2022 Song H, Weinstein HNW, Allegakoen P, Wadsworth MH, Xie J, Yang H, Castro EA, Lu KL, Stohr BA, Feng FY, Carroll PR, Wang B, Cooperberg MR, Shalek AK, Huang FW
• The Natural History of Untreated Biopsy Grade Group Progression and Delayed Definitive Treatment for Men on Active Surveillance for Early-Stage Prostate Cancer.
  The Journal of urology 2022 Chappidi MR, Bell A, Cowan JE, Greenberg SA, Lonergan PE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR
• Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer.
  JAMA oncology 2022 Wallis CJD, Zhao Z, Huang LC, Penson DF, Koyama T, Kaplan SH, Greenfield S, Luckenbaugh AN, Klaassen Z, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil…
• Changes in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer Screening.
  JAMA oncology 2022 Leapman MS, Wang R, Park H, Yu JB, Sprenkle PC, Cooperberg MR, Gross CP, Ma X
• Molecular risk classifier score and biochemical recurrence risk are associated with cribriform pattern type in Gleason 3+4=7 prostate cancer.
  Investigative and clinical urology 2022 Greenland NY, Cooperberg MR, Wong AC, Chan E, Carroll PR, Simko JP, Stohr BA
• Prostate weight and prostate cancer outcomes after radical prostatectomy: Results from the SEARCH cohort study.
  The Prostate 2021 Barlow SK, Oyekunle T, Janes JL, De Hoedt AM, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Klaassen ZW, Terris MK, Freedland SJ, Csizmadi I
• Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate Cancer.
  The Journal of urology 2021 Lonergan PE, Washington SL, Cowan JE, Zhao S, Broering JM, Cooperberg MR, Carroll PR
• Predictors of Regret among Older Men after Stress Urinary Incontinence Treatment Decisions.
  The Journal of urology 2021 Hampson LA, Suskind AM, Breyer BN, Cooperberg MR, Sudore RL, Keyhani S, Allen IE, Walter LC
• Corrigendum to "Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)" [Eur Urol 77 (2020) 713-24].
  European urology 2021 Wilt TJ, Vo TN, Langsetmo L, Dahm P, Wheeler T, Aronson WJ, Cooperberg MR, Taylor BC, Brawer MK
• Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.
  HGG advances 2021 Jiang Y, Meyers TJ, Emeka AA, Cooley LF, Cooper PR, Lancki N, Helenowski I, Kachuri L, Lin DW, Stanford JL, Newcomb LF, Kolb S, Finelli A, Fleshner NE, Komisarenko M, Eastham JA, Ehdaie B, Benfante N,…
• Active Surveillance: Very Much "Preferred" for Low-Risk Prostate Cancer.
  The Journal of urology 2021 Cooperberg MR, Lin DW, Morgan TM, Chapin BF, Chen RC, Eggener SE
• Hyperpolarized 1-[13C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Immune Checkpoint Inhibitor Therapy in Prostate Cancer.
  European urology 2021 de Kouchkovsky I, Chen HY, Ohliger MA, Wang ZJ, Bok RA, Gordon JW, Larson PEZ, Frost M, Okamoto K, Cooperberg MR, Kurhanewicz J, Vigneron DB, Aggarwal R
• Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial.
  JAMA oncology 2021 Hope TA, Eiber M, Armstrong WR, Juarez R, Murthy V, Lawhn-Heath C, Behr SC, Zhang L, Barbato F, Ceci F, Farolfi A, Schwarzenböck SM, Unterrainer M, Zacho HD, Nguyen HG, Cooperberg MR, Carroll PR, …
• Optimization of prostate biopsy - Micro-Ultrasound versus MRI (OPTIMUM): A 3-arm randomized controlled trial evaluating the role of 29 MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancer.
  Contemporary clinical trials 2021 Klotz L, Andriole G, Cash H, Cooperberg M, Crawford ED, Emberton M, Gomez-Sancha F, Klein E, Lughezzani G, Marks L, Montorsi F, Salomon G, Sanchez-Salas R, Shore N, Taneja S
• Association between Delay to Radical Prostatectomy and Clinically Meaningful Outcomes among Patients with Intermediate and High-Risk Localized Prostate Cancer.
  The Journal of urology 2021 Lee MC, Erickson TR, Stock S, Howard LE, De Hoedt AM, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Klaassen Z, Freedland SJ, Wallis CJD
• Active surveillance in intermediate-risk prostate cancer with PSA 10-20 ng/mL: pathological outcome analysis of a population-level database.
  Prostate cancer and prostatic diseases 2021 Lonergan PE, Jeong CW, Washington SL, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR
• Impact of the COVID-19 Pandemic on Urological Care Delivery in the United States.
  The Journal of urology 2021 Lee DJ, Shelton JB, Brendel P, Doraiswami R, Makarov D, Meeks W, Fang R, Roe MT, Cooperberg MR
• Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium.
  The Journal of urology 2021 Chang P, Wagner AA, Regan MM, Smith JA, Saigal CS, Litwin MS, Hu JC, Cooperberg MR, Carroll PR, Klein EA, Kibel AS, Andriole GL, Han M, Partin AW, Wood DP, Crociani CM, Greenfield TK, Patil D, …
• Individual Patient Data Meta-analysis of Discrimination of the Four Kallikrein Panel Associated With the Inclusion of Prostate Volume.
  Urology 2021 Vertosick EA, Zappala S, Punnen S, Hugosson J, Boorjian SA, Haese A, Carroll P, Cooperberg M, Bjartell A, Lilja H, Vickers AJ
• Association between pelvic nodal radiotherapy and patient-reported functional outcomes through 5 years among men undergoing external-beam radiotherapy for prostate cancer: An assessment of the comparative effectiveness analysis of surgery and radiation (CEASAR) cohort.
  Urologic oncology 2021 Wallis CJD, Huang LC, Zhao Z, Penson DF, Koyama T, Conwill R, Tallman JE, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Barocas DA,…
• Sexual function outcomes of radiation and androgen deprivation therapy for localized prostate cancer in men with good baseline function.
  Prostate cancer and prostatic diseases 2021 Joyce DD, Wallis CJD, Luckenbaugh AN, Huelster HL, Zhao Z, Hoffman KE, Huang LC, Koyama T, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, Neil BBO, Kaplan SH…
• Reply to Nicolas Mottet, Olivier Rouviere, and Theodorus H. van der Kwast. Incidental Prostate Cancer: A Real Need for Expansion in Guidelines? Eur Urol Oncol. In press: Incidental Prostate Cancer: An Example of How Important Guidelines Are, Especially When Evidence Is Limited.
  European urology oncology 2021 Capitanio U, Autorino R, Bandini M, Briganti A, Cheng L, Cooperberg MR, Dehò F, Gallina A, Klotz L, Lane BR, Montironi R, Salonia A, Stief C, Tombal B, Montorsi F
• Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy in a National Veterans Affairs Cohort.
  JAMA network open 2021 Vaculik K, Luu M, Howard LE, Aronson W, Terris M, Kane C, Amling C, Cooperberg M, Freedland SJ, Daskivich TJ
• Understanding the Health Characteristics and Treatment Choices of Older Men with Stress Urinary Incontinence.
  Urology 2021 Hampson LA, Suskind AM, Breyer BN, Lai L, Cooperberg MR, Sudore RL, Keyhani S, Allen IE, Walter LC
• SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study.
  Cancers 2021 Maggi M, Del Giudice F, Falagario UG, Cocci A, Russo GI, Di Mauro M, Sepe GS, Galasso F, Leonardi R, Iacona G, Carroll PR, Cooperberg MR, Porreca A, Ferro M, Lucarelli G, Terracciano D, Cormio L, …
• Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes.
  International journal of molecular sciences 2021 Salciccia S, Capriotti AL, Laganà A, Fais S, Logozzi M, De Berardinis E, Busetto GM, Di Pierro GB, Ricciuti GP, Del Giudice F, Sciarra A, Carroll PR, Cooperberg MR, Sciarra B, Maggi M
• Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer.
  European urology 2021 Chu CE, Alshalalfa M, Sjöström M, Zhao SG, Liu Y, Chou J, Herlemann A, Mahal B, Kishan AU, Spratt DE, Cooperberg M, Small E, Wong A, Porten S, Hope TA, Ross AE, Davicioni E, Nguyen P, Karnes RJ, …
• Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. Letter.
  The Journal of urology 2021 Gaylis FD, Cooperberg MR, Chen RC, Malin J, Loeb S, Witte JS, Carroll PR, Cohen ES, Dato PE, Lin DW, Zheng Y, Seibert TM, Setzler C, Wilt W, Gomez SL, Chan JML, Catalona WJ
• Incidental Prostate Cancer (cT1a-cT1b) Is a Relevant Clinical and Research Entity and Should Be Fully Discussed in the International Prostate Cancer Guidelines.
  European urology oncology 2021 Capitanio U, Autorino R, Bandini M, Briganti A, Cheng L, Cooperberg MR, Dehò F, Gallina A, Klotz L, Lane B, Montironi R, Salonia A, Stief C, Tombal B, Montorsi F
• Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world population.
  The Prostate 2021 Zhao H, Howard LE, De Hoedt AM, Terris MK, Amling CL, Kane CJ, Cooperberg MR, Aronson WJ, Klaassen Z, Polascik TJ, Vidal AC, Freedland SJ
• Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy.
  JNCI cancer spectrum 2021 Kelkar S, Oyekunle T, Eisenberg A, Howard L, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Klaassen Z, Terris MK, Freedland SJ, Csizmadi I
• Five-year outcomes from a prospective comparative effectiveness study evaluating external-beam radiotherapy with or without low-dose-rate brachytherapy boost for localized prostate cancer.
  Cancer 2021 Pasalic D, Barocas DA, Huang LC, Zhao Z, Koyama T, Tang C, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup AM, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Penson DF, …
• Monocyte counts and prostate cancer outcomes in white and black men: results from the SEARCH database.
  Cancer causes & control : CCC 2021 Yirga A, Oyekunle T, Howard LE, De Hoedt AM, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Taioli E, Fowke JH, Klaanssen Z, Freedland SJ, Vidal AC
• Prospective validation of microseminoprotein-β added to the 4Kscore in predicting high-grade prostate cancer in an international multicentre cohort.
  BJU international 2020 Lonergan PE, Vertosick EA, Assel M, Sjoberg DD, Haese A, Graefen M, Boorjian SA, Klee GG, Cooperberg MR, Pettersson K, Routila E, Vickers AJ, Lilja H
• A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer.
  European urology 2020 Jairath NK, Dal Pra A, Vince R, Dess RT, Jackson WC, Tosoian JJ, McBride SM, Zhao SG, Berlin A, Mahal BA, Kishan AU, Den RB, Freedland SJ, Salami SS, Kaffenberger SD, Pollack A, Tran P, Mehra R, …
• Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy.
  Urology 2020 Chu CE, Law L, Zuniga K, Lin TK, Tsourounis C, Rodriguez-Monguio R, Lazar A, Washington SL, Cooperberg MR, Greene KL, Carroll PR, Pruthi RS, Meng MV, Chen LL, Porten SP
• Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate.
  JAMA oncology 2020 Dess RT, Suresh K, Zelefsky MJ, Freedland SJ, Mahal BA, Cooperberg MR, Davis BJ, Horwitz EM, Terris MK, Amling CL, Aronson WJ, Kane CJ, Jackson WC, Hearn JWD, Deville C, DeWeese TL, Greco S, McNutt TR…
• Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US.
  JAMA network open 2020 Washington SL, Jeong CW, Lonergan PE, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR
• Patient-Reported Financial Toxicity Associated with Contemporary Treatment for Localized Prostate Cancer.
  The Journal of urology 2020 Stone BV, Laviana AA, Luckenbaugh AN, Huang LC, Zhao Z, Koyama T, Conwill R, Hoffman K, Joyce DD, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, …
• Do Hispanic Men Have Worse Outcomes After Radical Prostatectomy? Results From SEARCH.
  Urology 2020 Guerrios-Rivera L, Howard LE, Klaassen Z, Terris MK, Cooperberg MR, Amling CL, Kane CJ, Aronson WJ, Freedland SJ
• Reply by Authors.
  The Journal of urology 2020 Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW
• Monitoring Prostate Cancer Incidence Trends: Value of Multiple Imputation and Delay Adjustment to Discern Disparities in Stage-specific Trends.
  European urology 2020 Gomez SL, Washington SL, Cheng I, Huang FW, Cooperberg MR
• Reply to Yi Sun, Fengxiang Sun, Qiang Wei, Jin Huang, and Ruiqi Duan's Letter to the Editor re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304-6.
  European urology 2020 Vickers A, Carlsson SV, Cooperberg M
• Multiple Tissue Biomarkers Independently and Additively Predict Prostate Cancer Pathology Outcomes.
  European urology 2020 Cooperberg MR, Cowan JE, Lindquist KJ, Kobayashi Y, Simko JP, Bengtsson H, Singh K, Ngo V, Avila A, Newcomb LF, Tretriakova M, Lin DW, Stone S, Carroll PR, Paris PL
• Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the Prostate.
  JCO precision oncology 2020 Hall WA, Fishbane N, Liu Y, Xu MJ, Davicioni E, Mahal BA, Den RB, Dess RT, Jackson WC, Wong AC, Schaeffer EM, Karnes RJ, Carroll PR, Cooperberg MR, Bismar TA, Kim HL, Klein EA, Davis JW, Ross AE, …
• Natural language processing systems for pathology parsing in limited data environments with uncertainty estimation.
  JAMIA open 2020 Odisho AY, Park B, Altieri N, DeNero J, Cooperberg MR, Carroll PR, Yu B
• The Evolution of Our Understanding of the Biology of Cancer Is the Key to Avoiding Overdiagnosis and Overtreatment.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2020 Hewitt K, Son J, Glencer A, Borowsky AD, Cooperberg MR, Esserman LJ
• Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability.
  JAMA oncology 2020 Cooperberg MR, Zheng Y, Faino AV, Newcomb LF, Zhu K, Cowan JE, Brooks JD, Dash A, Gleave ME, Martin F, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Carroll PR, Lin DW
• Characteristics of Participants in the American Urological Association Quality (AQUA) Registry and Early Impact of Participation on Quality of Care.
  Urology practice 2020 Shelton JB, Pichardo D, Meeks W, Suh R, Wood EL, Smith N, Nolin M, Ross K, Schlossberg S, Wolf S, Fang R, Cooperberg MR
• Reply by Authors.
  The Journal of urology 2020 Lonergan PE, Washington SL, Cowan JE, Zhao S, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR
• Clinical Utility of 4Kscore®, ExosomeDx™ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer.
  The Journal of urology 2020 de la Calle CM, Fasulo V, Cowan JE, Lonergan PE, Maggi M, Gadzinski AJ, Yeung RA, Saita A, Cooperberg MR, Shinohara K, Carroll PR, Nguyen HG
• How Often Does Magnetic Resonance Imaging Detect Prostate Cancer Missed by Transrectal Ultrasound?
  European urology focus 2020 Herlemann A, Overland MR, Washington SL, Cowan JE, Westphalen AC, Carroll PR, Nguyen HG, Shinohara K, Cooperberg MR
• The Impact of Comorbidity and Age on Timing of Androgen Deprivation Therapy in Men with Biochemical Recurrence after Radical Prostatectomy.
  Urology practice 2020 Moradzadeh A, Howard LE, Freedland SJ, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Klaassen Z, Terris MK, Daskivich TJ
• Significant Management Variability of Urethral stricture Disease in United States: Data from the AUA Quality (AQUA) Registry.
  Urology 2020 Cohen AJ, Agochukwu-Mmonu N, Makarov DV, Meeks W, Murphy J, Fang R, Cooperberg MR, Breyer BN
• Radiotherapy after radical prostatectomy: Effect of timing of postprostatectomy radiation on functional outcomes.
  Urologic oncology 2020 Huelster HL, Laviana AA, Joyce DD, Huang LC, Zhao Z, Koyama T, Hoffman KE, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg M, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, …
• Obese men undergoing radical prostatectomy: Is robotic or retropubic better to limit positive surgical margins? Results from SEARCH.
  International journal of urology : official journal of the Japanese Urological Association 2020 Nik-Ahd F, Howard LE, Aronson WJ, Terris MK, Klaassen Z, Cooperberg MR, Amling CL, Kane CJ, Freedland SJ
• Multiparametric Magnetic Resonance Imaging Alone is Insufficient to Detect Grade Reclassification in Active Surveillance for Prostate Cancer.
  European urology 2020 Chu CE, Lonergan PE, Washington SL, Cowan JE, Shinohara K, Westphalen AC, Carroll PR, Cooperberg MR
• Reply to Roderick C.N. van den Bergh, Olivier Rouvière, and Theodorus van der Kwast's Letter to the Editor re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304-6. Prebiopsy MRI: Through the Looking Glass.
  European urology 2020 Vickers A, Carlsson SV, Cooperberg M
• Assessing the Quality of Surgical Care for Clinically Localized Prostate Cancer: Results from the CEASAR Study.
  The Journal of urology 2020 Reisz PA, Laviana AA, Zhao Z, Huang LC, Koyama T, Conwill R, Hoffman K, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Penson DF, …
• The Gender Pay Gap in Urology.
  Urology practice 2020 North AC, Fang R, Anger J, Breyer BN, Meeks W, Goldman HB, Cooperberg MR, Makarov DV
• Risk Factors for Biopsy Reclassification over Time in Men on Active Surveillance for Early Stage Prostate Cancer.
  The Journal of urology 2020 Lonergan PE, Washington SL, Cowan JE, Zhao S, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR
• Obesity, race, and long-term prostate cancer outcomes.
  Cancer 2020 Vidal AC, Oyekunle T, Howard LE, De Hoedt AM, Kane CJ, Terris MK, Cooperberg MR, Amling CL, Klaassen Z, Freedland SJ, Aronson WJ
• The Relative Impact of Urinary and Sexual Function vs Bother on Health Utility for Men With Prostate Cancer.
  JNCI cancer spectrum 2020 Jeong CW, Herlemann A, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR
• Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence.
  European urology 2020 Vickers A, Carlsson SV, Cooperberg M
• Expression of ACE2, the SARS-CoV-2 Receptor, and TMPRSS2 in Prostate Epithelial Cells.
  European urology 2020 Song H, Seddighzadeh B, Cooperberg MR, Huang FW
• Race does not predict skeletal-related events and all-cause mortality in men with castration-resistant prostate cancer.
  Cancer 2020 Patel DN, Howard LE, De Hoedt AM, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Klaassen ZW, Terris MK, Freedland SJ
• Magnetic Resonance Imaging for the Detection of High Grade Cancer in the Canary Prostate Active Surveillance Study.
  The Journal of urology 2020 Liss MA, Newcomb LF, Zheng Y, Garcia MP, Filson CP, Boyer H, Brooks JD, Carroll PR, Cooperberg MR, Ellis WJ, Gleave ME, Martin FM, Morgan T, Nelson PS, Wagner AA, Thompson IM, Lin DW
• Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells.
  bioRxiv : the preprint server for biology 2020 Song H, Seddighzadeh B, Cooperberg MR, Huang FW
• Traditional and Virtual Congress Meetings During the COVID-19 Pandemic and the Post-COVID-19 Era: Is it Time to Change the Paradigm?
  European urology 2020 Porpiglia F, Checcucci E, Autorino R, Amparore D, Cooperberg MR, Ficarra V, Novara G
• Intermediate-risk Prostate Cancer: Stratification and Management.
  European urology oncology 2020 Preisser F, Cooperberg MR, Crook J, Feng F, Graefen M, Karakiewicz PI, Klotz L, Montironi R, Nguyen PL, D'Amico AV
• Active Surveillance for Prostate Cancer: A 2020 Vision.
  European urology 2020 Cooperberg MR, Lin DW
• Competing Risks of Mortality among Men with Biochemical Recurrence after Radical Prostatectomy.
  The Journal of urology 2020 Daskivich TJ, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Klaassen Z, Terris MK, Freedland SJ
• Reply to Potential underestimation of cerebrovascular events in the PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data.
  Cancer 2020 Higano CS, Armstrong AJ, Sartor O, Vogelzang NJ, Kantoff PW, McLeod DG, Pieczonka CM, Penson DF, Shore ND, Vacirca J, Concepcion RS, Tutrone RF, Nordquist LT, Quinn DI, Kassabian V, Scholz MC, Harmon …
• Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry.
  Prostate cancer and prostatic diseases 2020 Sartor O, Armstrong AJ, Ahaghotu C, McLeod DG, Cooperberg MR, Penson DF, Kantoff PW, Vogelzang NJ, Hussain A, Pieczonka CM, Shore ND, Quinn DI, Small EJ, Heath EI, Tutrone RF, Schellhammer PF, Harmon …
• Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or Observation.
  European urology 2020 Laviana AA, Zhao Z, Huang LC, Koyama T, Conwill R, Hoffman K, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Penson DF, Barocas DA
• Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT).
  European urology 2020 Wilt TJ, Vo TN, Langsetmo L, Dahm P, Wheeler T, Aronson WJ, Cooperberg MR, Taylor BC, Brawer MK
• The New Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting Database: Opportunities and Limitations.
  European urology 2020 Jeong CW, Washington SL, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR
• Reply by Authors.
  The Journal of urology 2020 Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW
• Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.
  JAMA 2020 Hoffman KE, Penson DF, Zhao Z, Huang LC, Conwill R, Laviana AA, Joyce DD, Luckenbaugh AN, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, …
• Veterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High-risk Prostate Carcinoma: A Phase III Randomized Study.
  European urology 2020 Lin DW, Shih MC, Aronson W, Basler J, Beer TM, Brophy M, Cooperberg M, Garzotto M, Kelly WK, Lee K, McGuire V, Wang Y, Lu Y, Markle V, Nseyo U, Ringer R, Savage SJ, Sinnott P, Uchio E, Yang CC, …
• Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients.
  Cancer medicine 2019 Belkora J, Chan JM, Cooperberg MR, Neuhaus J, Stupar L, Weinberg T, Broering JM, Tenggara I, Cowan JE, Rosenfeld S, Kenfield SA, Van Blarigan EL, Simko JP, Witte J, Carroll PR
• Understanding the Major Factors Affecting Response Shift Effects on Health-Related Quality of Life: What the Then-Test Measures in a Longitudinal Prostate Cancer Registry.
  Clinical genitourinary cancer 2019 Ten Ham RMT, Broering JM, Cooperberg MR, Carroll P, Wilson LS
• Active surveillance for intermediate-risk prostate cancer: yes, but for whom?
  Current opinion in urology 2019 Overland MR, Washington SL, Carroll PR, Cooperberg MR, Herlemann A
• African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study.
  The Journal of urology 2019 Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW
• Reply by Authors.
  The Journal of urology 2019 Dambal S, Howard LE, Allott EH, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Freedland SJ
• A 17-Gene Genomic Prostate Score as a Predictor of Adverse Pathology in Men on Active Surveillance.
  The Journal of urology 2019 Kornberg Z, Cooperberg MR, Cowan JE, Chan JM, Shinohara K, Simko JP, Tenggara I, Carroll PR
• Identification and Characterization of Circulating Tumor Cells in Men Who have Undergone Prostatectomy for Clinically Localized, High Risk Prostate Cancer.
  The Journal of urology 2019 Friedlander TW, Welty C, Anantharaman A, Schonhoft JD, Jendrisak A, Lee J, Li P, Hough J, Stromlund A, Edwards M, Sangar S, Kobayashi Y, Simko J, Farrokhian N, Lindquist K, Greene S, Ontiveros P, Graf…
• Stability of a 17-Gene Genomic Prostate Score in Serial Testing of Men on Active Surveillance for Early Stage Prostate Cancer.
  The Journal of urology 2019 Cedars BE, Washington SL, Cowan JE, Leapman M, Tenggara I, Chan JM, Cooperberg MR, Carroll PR
• Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer.
  Cancer 2019 Higano CS, Armstrong AJ, Sartor AO, Vogelzang NJ, Kantoff PW, McLeod DG, Pieczonka CM, Penson DF, Shore ND, Vacirca J, Concepcion RS, Tutrone RF, Nordquist LT, Quinn DI, Kassabian V, Scholz MC, Harmon…
• Racial Discrepancies in Overall Survival among Men Treated with 223Radium.
  The Journal of urology 2019 Zhao H, Howard LE, De Hoedt A, Terris MK, Amling CL, Kane CJ, Cooperberg MR, Aronson WJ, Klaassen Z, Polascik TJ, Vidal AC, Freedland SJ
• Obesity at Diagnosis and Prostate Cancer Prognosis and Recurrence Risk Following Primary Treatment by Radical Prostatectomy.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2019 Langlais CS, Cowan JE, Neuhaus J, Kenfield SA, Van Blarigan EL, Broering JM, Cooperberg MR, Carroll P, Chan JM
• Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance.
  Prostate cancer and prostatic diseases 2019 Herlemann A, Huang HC, Alam R, Tosoian JJ, Kim HL, Klein EA, Simko JP, Chan JM, Lane BR, Davis JW, Davicioni E, Feng FY, McCue P, Kim H, Den RB, Bismar TA, Carroll PR, Cooperberg MR
• Serum Lipids prior to Starting Androgen Deprivation Therapy and Risk of Castration Resistant Prostate Cancer and Metastasis: Results from the SEARCH Database.
  The Journal of urology 2019 Dambal S, Howard LE, Allott EH, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Freedland SJ
• Evaluating the Safety of Active Surveillance: Outcomes of Deferred Radical Prostatectomy after an Initial Period of Surveillance.
  The Journal of urology 2019 Balakrishnan AS, Cowan JE, Cooperberg MR, Shinohara K, Nguyen HG, Carroll PR
• Predictors of skeletal-related events and mortality in men with metastatic, castration-resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
  Cancer 2019 Tablazon IL, Howard LE, De Hoedt AM, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Freedland SJ, Williams SB
• Robust Health Utility Assessment Among Long-term Survivors of Prostate Cancer: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Registry.
  European urology 2019 Jeong CW, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR
• Prostate cancer screening in low- and middle-income countries: the Mexican case.
  Salud publica de Mexico 2019 Lajous M, Cooperberg MR, Rider J, Manzanilla-García HA, Gabilondo-Navarro FB, Rodríguez-Covarrubias FT, López-Ridaura R, Torres-Sánchez LE, Mohar A
• Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.
  JAMA oncology 2019 Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Cooperberg MR, Amling CL, Aronson WJ, Kane CJ, Terris MK, Zumsteg ZS, Butler S, Osborne JR, Morgan TM, Mehra R, Salami SS, Kishan AU, Wang C, …
• Automating the Capture of Structured Pathology Data for Prostate Cancer Clinical Care and Research.
  JCO clinical cancer informatics 2019 Odisho AY, Bridge M, Webb M, Ameli N, Eapen RS, Stauf F, Cowan JE, Washington SL, Herlemann A, Carroll PR, Cooperberg MR
• Interpretation of Domain Scores on the EPIC-How Does the Domain Score Translate into Functional Outcomes?
  The Journal of urology 2019 Laviana AA, Hernandez A, Huang LC, Zhao Z, Koyama T, Conwill R, Hoffman K, Feurer ID, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S,…
• Trends and Predictors of Adjuvant Therapy for Adverse Features Following Radical Prostatectomy: An Analysis From Cancer of the Prostate Strategic Urologic Research Endeavor.
  Urology 2019 Balakrishnan AS, Zhao S, Cowan JE, Broering JM, Cooperberg MR, Carroll PR
• Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing?
  Clinical genitourinary cancer 2019 Tay KJ, Polascik TJ, Howard LE, Salama JK, Schulman AA, Chen Z, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Freedland SJ
• The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement.
  European urology 2019 Cooperberg MR, Carroll PR, Dall'Era MA, Davies BJ, Davis JW, Eggener SE, Feng FY, Lin DW, Morgan TM, Morgans AK, Spratt DE, Taneja SS, Penson DF
• Association Between Twitter Reception at a National Urology Conference and Future Publication Status.
  European urology focus 2019 Nolte AC, Nguyen KA, Perecman A, Katz MS, Kenney PA, Cooperberg MR, Gross CP, Leapman MS
• Influence of African American race on the association between preoperative biopsy grade group and adverse histopathologic features of radical prostatectomy.
  Cancer 2019 Aminsharifi A, Schulman A, Howard LE, Tay KJ, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Freedland SJ, Polascik TJ
• Poorly controlled diabetes increases the risk of metastases and castration-resistant prostate cancer in men undergoing radical prostatectomy: Results from the SEARCH database.
  Cancer 2019 Nik-Ahd F, Howard LE, Eisenberg AT, Aronson WJ, Terris MK, Cooperberg MR, Amling CL, Kane CJ, Freedland SJ
• Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancer.
  Prostate cancer and prostatic diseases 2019 Moghanaki D, Howard LE, De Hoedt A, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Freedland SJ
• Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies.
  International journal of radiation oncology, biology, physics 2019 Jackson WC, Silva J, Hartman HE, Dess RT, Kishan AU, Beeler WH, Gharzai LA, Jaworski EM, Mehra R, Hearn JWD, Morgan TM, Salami SS, Cooperberg MR, Mahal BA, Soni PD, Kaffenberger S, Nguyen PL, Desai N,…
• The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target.
  Journal of the National Cancer Institute 2019 Zhao SG, Lehrer J, Chang SL, Das R, Erho N, Liu Y, Sjöström M, Den RB, Freedland SJ, Klein EA, Karnes RJ, Schaeffer EM, Xu M, Speers C, Nguyen PL, Ross AE, Chan JM, Cooperberg MR, Carroll PR, …
• High-throughput, Efficient, and Unbiased Capture of Small RNAs from Low-input Samples for Sequencing.
  Scientific reports 2019 Belair CD, Hu T, Chu B, Freimer JW, Cooperberg MR, Blelloch RH
• Genomic Prostate Score, PI-RADS™ version 2 and Progression in Men with Prostate Cancer on Active Surveillance.
  The Journal of urology 2019 Kornberg Z, Cowan JE, Westphalen AC, Cooperberg MR, Chan JM, Zhao S, Shinohara K, Carroll PR
• First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH.
  Cancer causes & control : CCC 2019 Griffin K, Csizmadi I, Howard LE, Pomann GM, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Beebe-Dimmer J, Freedland SJ
• Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project.
  World journal of urology 2019 van Luijtelaar A, Greenwood BM, Ahmed HU, Barqawi AB, Barret E, Bomers JGR, Brausi MA, Choyke PL, Cooperberg MR, Eggener S, Feller JF, Frauscher F, George AK, Hindley RG, Jenniskens SFM, Klotz L, …
• Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS).
  Prostate cancer and prostatic diseases 2019 Newcomb LF, Zheng Y, Faino AV, Bianchi-Frias D, Cooperberg MR, Brown MD, Brooks JD, Dash A, Fabrizio MD, Gleave ME, Liss M, Morgan TM, Thompson IM, Wagner AA, Carroll PR, Nelson PS, Lin DW
• Practice patterns and outcomes of equivocal bone scans for patients with castration-resistant prostate cancer: Results from SEARCH.
  Asian journal of urology 2019 Hanyok BT, Everist MM, Howard LE, De Hoedt AM, Aronson WJ, Cooperberg MR, Kane CJ, Amling CL, Terris MK, Freedland SJ
• Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer.
  European urology oncology 2019 Xu MJ, Kornberg Z, Gadzinski AJ, Diao D, Cowan JE, Wu SY, Boreta L, Spratt DE, Behr SC, Nguyen HG, Cooperberg MR, Davicioni E, Roach M, Hope TA, Carroll PR, Feng FY
• Feasibility, Acceptability, and Behavioral Outcomes from a Technology-enhanced Behavioral Change Intervention (Prostate 8): A Pilot Randomized Controlled Trial in Men with Prostate Cancer.
  European urology 2019 Kenfield SA, Van Blarigan EL, Ameli N, Lavaki E, Cedars B, Paciorek AT, Monroy C, Tantum LK, Newton RU, Signorell C, Suh JH, Zhang L, Cooperberg MR, Carroll PR, Chan JM
• Socioeconomic status, race, and long-term outcomes after radical prostatectomy in an equal access health system: Results from the SEARCH database.
  Urologic oncology 2018 Everist MM, Howard LE, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Freedland SJ
• Health Care Delivery for Metastatic Hormone-sensitive Prostate Cancer Across the Globe.
  European urology focus 2018 Herlemann A, Washington SL, Cooperberg MR
• Phase I Study of CTT1057, an 18F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2018 Behr SC, Aggarwal R, VanBrocklin HF, Flavell RR, Gao K, Small EJ, Blecha J, Jivan S, Hope TA, Simko JP, Kurhanewicz J, Noworolski SM, Korn NJ, De Los Santos R, Cooperberg MR, Carroll PR, Nguyen HG, …
• Obesity, risk of biochemical recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database.
  BJU international 2018 Freedland SJ, Branche BL, Howard LE, Hamilton RJ, Aronson WJ, Terris MK, Cooperberg MR, Amling CL, Kane CJ, SEARCH Database Study Group
• Does race predict the development of metastases in men who receive androgen-deprivation therapy for a biochemical recurrence after radical prostatectomy?
  Cancer 2018 Vidal AC, Howard LE, De Hoedt A, Kane CJ, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Lechpammer S, Flanders SC, Freedland SJ
• PSMA PET applications in the prostate cancer journey: from diagnosis to theranostics.
  World journal of urology 2018 Eapen RS, Nzenza TC, Murphy DG, Hofman MS, Cooperberg M, Lawrentschuk N
• Statins are Associated With Increased Biochemical Recurrence After Radical Prostatectomy in Diabetic Men but no Association was Seen in Men also Taking Metformin: Results From the SEARCH Database.
  Clinical genitourinary cancer 2018 Aminsharifi A, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Polascik TJ, Freedland SJ
• Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancer.
  Prostate cancer and prostatic diseases 2018 Whitney CA, Howard LE, Freedland SJ, DeHoedt AM, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Daskivich TJ
• Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital.
  International journal of urology : official journal of the Japanese Urological Association 2018 Patel DN, Jha S, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Chapin BF, Freedland SJ
• ESTIMATING AND COMPARING CANCER PROGRESSION RISKS UNDER VARYING SURVEILLANCE PROTOCOLS.
  The annals of applied statistics 2018 Lange JM, Gulati R, Leonardson AS, Lin DW, Newcomb LF, Trock BJ, Carter HB, Cooperberg MR, Cowan JE, Klotz LH, Etzioni R
• Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy.
  European urology 2018 Leapman MS, Nguyen HG, Cowan JE, Xue L, Stohr B, Simko J, Cooperberg MR, Carroll PR
• Contemporary prostate cancer radiation therapy in the United States: Patterns of care and compliance with quality measures.
  Practical radiation oncology 2018 Lee DJ, Barocas DA, Zhao Z, Huang LC, Koyama T, Resnick MJ, Conwill R, McCollum D, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Penson DF, …
• Online Professionalism-2018 Update of European Association of Urology (@Uroweb) Recommendations on the Appropriate Use of Social Media.
  European urology 2018 Borgmann H, Cooperberg M, Murphy D, Loeb S, N'Dow J, Ribal MJ, Woo H, Rouprêt M, Winterbottom A, Wijburg C, Wirth M, Catto J, Kutikov A
• Practice patterns of primary EBRT with and without ADT in prostate cancer treatment.
  Prostate cancer and prostatic diseases 2018 Schmidt B, Eapen RS, Cowan JE, Broering JM, Greene KL, Carroll PR, Cooperberg MR
• Measuring quality of urology care using a qualified clinical data registry.
  Current opinion in urology 2018 Gadzinski AJ, Cooperberg MR
• Report of the third Asian Prostate Cancer study meeting.
  Prostate international 2018 Lojanapiwat B, Lee JY, Gang Z, Kim CS, Fai NC, Hakim L, Umbas R, Ong TA, Lim J, Letran JL, Chiong E, Lee SH, Türkeri L, Murphy DG, Moretti K, Cooperberg M, Carlile R, Hinotsu S, Hirao Y, Kitamura T, …
• Comparison of Patient-reported Outcomes After External Beam Radiation Therapy and Combined External Beam With Low-dose-rate Brachytherapy Boost in Men With Localized Prostate Cancer.
  International journal of radiation oncology, biology, physics 2018 Lee DJ, Barocas DA, Zhao Z, Huang LC, Resnick MJ, Koyoma T, Conwill R, McCollum D, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Penson DF, …
• Genomic biomarkers in prostate cancer.
  Translational andrology and urology 2018 Kornberg Z, Cooperberg MR, Spratt DE, Feng FY
• The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer.
  European urology 2018 Cooperberg MR, Erho N, Chan JM, Feng FY, Fishbane N, Zhao SG, Simko JP, Cowan JE, Lehrer J, Alshalalfa M, Kolisnik T, Chelliserry J, Margrave J, Aranes M, Plessis MD, Buerki C, Tenggara I, Davicioni E…
• Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer.
  European urology oncology 2018 Masic S, Cowan JE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR
• A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts.
  European urology 2018 Ankerst DP, Straubinger J, Selig K, Guerrios L, De Hoedt A, Hernandez J, Liss MA, Leach RJ, Freedland SJ, Kattan MW, Nam R, Haese A, Montorsi F, Boorjian SA, Cooperberg MR, Poyet C, Vertosick E, …
• Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer.
  European urology oncology 2018 Aggarwal R, Wei X, Kim W, Small EJ, Ryan CJ, Carroll P, Cooperberg M, Evans MJ, Hope T
• Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database.
  Cancer causes & control : CCC 2018 Vidal AC, Howard LE, de Hoedt A, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Taioli E, Fowke JH, Freedland SJ
• Obese patients with castration-resistant prostate cancer may be at a lower risk of all-cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
  BJU international 2018 Vidal AC, Howard LE, de Hoedt A, Kane CJ, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Freedland SJ
• The Research Implications of Prostate Specific Antigen Registry Errors: Data from the Veterans Health Administration.
  The Journal of urology 2018 Guo DP, Thomas IC, Mittakanti HR, Shelton JB, Makarov DV, Skolarus TA, Cooperberg MR, Sonn GA, Chung BI, Brooks JD, Leppert JT
• Radical prostatectomy and the effect of close surgical margins: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
  BJU international 2018 Herforth C, Stroup SP, Chen Z, Howard LE, Freedland SJ, Moreira DM, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Kane CJ
• How Should a Man with Prostate Cancer Choose his Surgeon?
  European urology 2018 Cooperberg MR
• Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results.
  European urology 2018 Tyson MD, Koyama T, Lee D, Hoffman KE, Resnick MJ, Wu XC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Paddock LE, Stroup A, Chen V, Conwill R, McCollum D, Penson DF, Barocas DA
• First postoperative PSA is associated with outcomes in patients with node positive prostate cancer: Results from the SEARCH database.
  Urologic oncology 2018 McDonald ML, Howard LE, Aronson WJ, Terris MK, Cooperberg MR, Amling CL, Freedland SJ, Kane CJ
• Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes.
  European urology 2018 Cooperberg MR, Brooks JD, Faino AV, Newcomb LF, Kearns JT, Carroll PR, Dash A, Etzioni R, Fabrizio MD, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW, Zheng Y
• Prostate Cancer Markers.
  Cancer treatment and research 2018 Gadzinski AJ, Cooperberg MR
• The Effect of Nerve Sparing Status on Sexual and Urinary Function: 3-Year Results from the CEASAR Study.
  The Journal of urology 2017 Avulova S, Zhao Z, Lee D, Huang LC, Koyama T, Hoffman KE, Conwill RM, Wu XC, Chen V, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Paddock LE, Stroup A, Resnick MJ, Penson DF, …
• Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, Dicker AP, Eggener S, Fleshner N…
• The use of PET/CT in prostate cancer.
  Prostate cancer and prostatic diseases 2017 Li R, Ravizzini GC, Gorin MA, Maurer T, Eiber M, Cooperberg MR, Alemozzaffar M, Tollefson MK, Delacroix SE, Chapin BF
• Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy.
  JAMA oncology 2017 Zhao SG, Chang SL, Erho N, Yu M, Lehrer J, Alshalalfa M, Speers C, Cooperberg MR, Kim W, Ryan CJ, Den RB, Freedland SJ, Posadas E, Sandler H, Klein EA, Black P, Seiler R, Tomlins SA, Chinnaiyan AM, …
• Declining Incidence Rates of Prostate Cancer in the United States: Is This Good News or Not?
  JAMA oncology 2017 Downer MK, Stampfer MJ, Cooperberg MR
• Re: Follow-up of Prostatectomy Versus Observation for Early Prostate Cancer.
  European urology 2017 Cooperberg MR
• Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts.
  Annals of internal medicine 2017 Inoue LYT, Lin DW, Newcomb LF, Leonardson AS, Ankerst D, Gulati R, Carter HB, Trock BJ, Carroll PR, Cooperberg MR, Cowan JE, Klotz LH, Mamedov A, Penson DF, Etzioni R
• Genomic Markers in Prostate Cancer Decision Making.
  European urology 2017 Cucchiara V, Cooperberg MR, Dall'Era M, Lin DW, Montorsi F, Schalken JA, Evans CP
• Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic Classifier.
  The Urologic clinics of North America 2017 Herlemann A, Washington SL, Eapen RS, Cooperberg MR
• Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa).
  PloS one 2017 Leapman MS, Westphalen AC, Ameli N, Lawrence HJ, Febbo PG, Cooperberg MR, Carroll PR
• Modified risk stratification grouping using standard clinical and biopsy information for patients undergoing radical prostatectomy: Results from SEARCH.
  The Prostate 2017 Zumsteg ZS, Chen Z, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Spratt DE, Sandler HM, Freedland SJ
• Patient Reported Comparative Effectiveness of Contemporary Intensity Modulated Radiation Therapy Versus External Beam Radiation Therapy of the Mid 1990s for Localized Prostate Cancer.
  Urology practice 2017 O'Neil B, Hoffman KE, Koyama T, Alvarez JR, Conwill RM, Albertsen PC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Kaplan SH, Hashibe M, Stanford JL, Stroup AM, Paddock LE, Chen V, Wu XC, …
• Active Surveillance for Low-Risk Prostate Cancer-An Evolving International Standard of Care.
  JAMA oncology 2017 Cooperberg MR
• Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical Prostatectomy.
  The Journal of urology 2017 Nguyen HG, Welty C, Lindquist K, Ngo V, Gilbert E, Bengtsson H, Magi-Galluzzi C, Jean-Gilles J, Yao J, Cooperberg M, Messing E, Klein EA, Carroll PR, Paris PL
• The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy.
  Cancer 2017 Welty CJ, Sanford TH, Wright JL, Carroll PR, Cooperberg MR, Meng MV, Porten SP
• Does Early Prostate Specific Antigen Doubling Time after Radical Prostatectomy, Calculated Prior to Prostate Specific Antigen Recurrence, Correlate with Prostate Cancer Outcomes? A Report from the SEARCH Database Group.
  The Journal of urology 2017 Teeter AE, Griffin K, Howard LE, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ
• Outcomes of men on active surveillance for low-risk prostate cancer at a safety-net hospital.
  Urologic oncology 2017 Osterberg EC, Palmer NRA, Harris CR, Murphy GP, Blaschko SD, Chu C, Allen IE, Cooperberg MR, Carroll PR, Breyer BN
• Timing of Prostate-specific Antigen Nadir After Radical Prostatectomy and Risk of Biochemical Recurrence.
  Urology 2017 Skove SL, Howard LE, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Moreira DM, Freedland SJ
• A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer.
  European urology 2017 Spratt DE, Dess RT, Zumsteg ZS, Lin DW, Tran PT, Morgan TM, Antonarakis ES, Nguyen PL, Ryan CJ, Sandler HM, Cooperberg MR, Posadas E, Feng FY
• Biopsy Detected Gleason Pattern 5 is Associated with Recurrence, Metastasis and Mortality in a Cohort of Men with High Risk Prostate Cancer.
  The Journal of urology 2017 Stroup SP, Moreira DM, Chen Z, Howard L, Berger JH, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Kane CJ, Freedland SJ
• Predictors of operative time during radical retropubic prostatectomy and robot-assisted laparoscopic prostatectomy.
  International journal of urology : official journal of the Japanese Urological Association 2017 Simon RM, Howard LE, Moreira DM, Terris MK, Kane CJ, Aronson WJ, Amling CL, Cooperberg MR, Freedland SJ
• Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health system.
  Cancer 2017 Schulman AA, Howard LE, Tay KJ, Tsivian E, Sze C, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Freedland SJ, Polascik TJ
• Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.
  Cancer 2017 Freedland SJ, Vidal AC, Howard LE, Terris MK, Cooperberg MR, Amling CL, Kane CJ, Aronson WJ, Shared Equal Access Regional Cancer Hospital (SEARCH) Database Study Group
• Characterization of a "low-risk" cohort of grade group 2 prostate cancer patients: Results from the Shared Equal Access Regional Cancer Hospital database.
  International journal of urology : official journal of the Japanese Urological Association 2017 McGinley KF, Sun X, Howard LE, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ
• The New US Preventive Services Task Force "C" Draft Recommendation for Prostate Cancer Screening.
  European urology 2017 Cooperberg MR
• Impact of 68Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017 Hope TA, Aggarwal R, Chee B, Tao D, Greene KL, Cooperberg MR, Feng F, Chang A, Ryan CJ, Small EJ, Carroll PR
• Epidemiology of prostate cancer.
  World journal of urology 2017 Cooperberg MR, Chan JM
• Community-based Outcomes of Open versus Robot-assisted Radical Prostatectomy.
  European urology 2017 Herlemann A, Cowan JE, Carroll PR, Cooperberg MR
• Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging.
  Current opinion in urology 2017 Eapen RS, Herlemann A, Washington SL, Cooperberg MR
• Thresholds for PSA doubling time in men with non-metastatic castration-resistant prostate cancer.
  BJU international 2017 Howard LE, Moreira DM, De Hoedt A, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Freedland SJ
• Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features.
  European urology 2017 Karnes RJ, Choeurng V, Ross AE, Schaeffer EM, Klein EA, Freedland SJ, Erho N, Yousefi K, Takhar M, Davicioni E, Cooperberg MR, Trock BJ
• Report of the Second Asian Prostate Cancer (A-CaP) Study Meeting.
  Prostate international 2017 Kim CS, Lee JY, Chung BH, Kim WJ, Fai NC, Hakim L, Umbas R, Ong TA, Lim J, Letran JL, Chiong E, Wu TL, Lojanapiwat B, Türkeri L, Murphy DG, Gardiner RA, Moretti K, Cooperberg M, Carroll P, Mun SK, …
• Active Surveillance in Younger Men With Prostate Cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Leapman MS, Cowan JE, Nguyen HG, Shinohara KK, Perez N, Cooperberg MR, Catalona WJ, Carroll PR
• Interpreting Patient Reported Urinary and Sexual Function Outcomes across Multiple Validated Instruments.
  The Journal of urology 2017 Vertosick EA, Vickers AJ, Cowan JE, Broering JM, Carroll PR, Cooperberg MR
• Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.
  JAMA 2017 Barocas DA, Alvarez J, Resnick MJ, Koyama T, Hoffman KE, Tyson MD, Conwill R, McCollum D, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan SH, Paddock LE, Stroup AM, Wu XC, …
• Clinical risk-stratification for prostate cancer: Where are we, and where do we need to go?
  Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2017 Cooperberg MR
• The Influence of Psychosocial Constructs on the Adherence to Active Surveillance for Localized Prostate Cancer in a Prospective, Population-based Cohort.
  Urology 2017 Lang MF, Tyson MD, Alvarez JR, Koyama T, Hoffman KE, Resnick MJ, Cooperberg MR, Wu XC, Chen V, Paddock LE, Hamilton AS, Hashibe M, Goodman M, Greenfield S, Kaplan SH, Stroup A, Penson DF, Barocas DA
• Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancer.
  Cancer 2016 Klaassen Z, Howard LE, de Hoedt A, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Freedland SJ
• Clinically localized prostate cancer in 2017: A review of comparative effectiveness.
  Urologic oncology 2016 Lavery HJ, Cooperberg MR
• Application of a Prognostic Gleason Grade Grouping System to Assess Distant Prostate Cancer Outcomes.
  European urology 2016 Leapman MS, Cowan JE, Simko J, Roberge G, Stohr BA, Carroll PR, Cooperberg MR
• Tissue Sources for Accurate Measurement of Germline DNA Genotypes in Prostate Cancer Patients Treated With Radical Prostatectomy.
  The Prostate 2016 Emami NC, Leong L, Wan E, Van Blarigan EL, Cooperberg MR, Tenggara I, Carroll PR, Chan JM, Witte JS, Simko JP
• Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study.
  European urology 2016 Lin DW, Newcomb LF, Brown MD, Sjoberg DD, Dong Y, Brooks JD, Carroll PR, Cooperberg M, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Zheng Y, Canary Prostate …
• Magnetic Resonance Imaging-targeted Prostate Biopsies: Is the Right Technique the Right Question?
  European urology 2016 Cooperberg MR
• Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study.
  European urology 2016 Tyson MD, Alvarez J, Koyama T, Hoffman KE, Resnick MJ, Wu XC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Paddock LE, Stroup A, Chen VW, Penson DF, Barocas DA
• Re: 10-Year Outcomes After Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.
  European urology 2016 Cooperberg MR
• Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort.
  The American journal of surgical pathology 2016 McKenney JK, Wei W, Hawley S, Auman H, Newcomb LF, Boyer HD, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Tretiakova MS, Vakar-Lopez F, Carroll PR, Cooperberg MR, Gleave ME, Lance RS, Lin DW, Nelson …
• What Early ProtecT Results Have Confirmed About Risk-stratified Prostate Cancer Management.
  European urology 2016 Cooperberg MR
• Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis.
  The Lancet. Oncology 2016 Zhao SG, Chang SL, Spratt DE, Erho N, Yu M, Ashab HA, Alshalalfa M, Speers C, Tomlins SA, Davicioni E, Dicker AP, Carroll PR, Cooperberg MR, Freedland SJ, Karnes RJ, Ross AE, Schaeffer EM, Den RB, …
• Accuracy of Prostate-Specific Antigen Values in Prostate Cancer Registries.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Mittakanti HR, Thomas IC, Shelton JB, Makarov DV, Skolarus TA, Cooperberg MR, Chung BI, Sonn GA, Brooks JD, Leppert JT
• Long-term oncological outcomes of apical positive surgical margins at radical prostatectomy in the Shared Equal Access Regional Cancer Hospital cohort.
  Prostate cancer and prostatic diseases 2016 Wadhwa H, Terris MK, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ, Abern MR
• Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
  Prostate cancer and prostatic diseases 2016 Vidal AC, Howard LE, Sun SX, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Freedland SJ
• Number of Unfavorable Intermediate-Risk Factors Predicts Pathologic Upstaging and Prostate Cancer-Specific Mortality Following Radical Prostatectomy: Results From the SEARCH Database.
  The Prostate 2016 Zumsteg ZS, Chen Z, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Spratt DE, Sandler HM, Freedland SJ
• Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer.
  Cancer immunology research 2016 Wei XX, Chan S, Kwek S, Lewis J, Dao V, Zhang L, Cooperberg MR, Ryan CJ, Lin AM, Friedlander TW, Rini B, Kane C, Simko JP, Carroll PR, Small EJ, Fong L
• A Randomized Study of Intraoperative Autologous Retropubic Urethral Sling on Urinary Control after Robotic Assisted Radical Prostatectomy.
  The Journal of urology 2016 Nguyen HG, Punnen S, Cowan JE, Leapman M, Cary C, Welty C, Weinberg V, Cooperberg MR, Meng MV, Greene KL, Garcia M, Carroll PR
• The AUA Quality Registry: Engaging Stakeholders to Improve the Quality of Care for Patients with Prostate Cancer.
  Urology practice 2016 Cooperberg MR, Fang R, Schlossberg S, Wolf JS, Clemens JQ
• Editorial Commentary.
  Urology practice 2016 Cooperberg MR
• The CAPRA Score at 10 Years: Contemporary Perspectives and Analysis of Supporting Studies.
  European urology 2016 Brajtbord JS, Leapman MS, Cooperberg MR
• Temporal Trends and the Impact of Race, Insurance, and Socioeconomic Status in the Management of Localized Prostate Cancer.
  European urology 2016 Gray PJ, Lin CC, Cooperberg MR, Jemal A, Efstathiou JA
• Predicting Time From Metastasis to Overall Survival in Castration-Resistant Prostate Cancer: Results From SEARCH.
  Clinical genitourinary cancer 2016 Moreira DM, Howard LE, Sourbeer KN, Amarasekara HS, Chow LC, Cockrell DC, Pratson CL, Hanyok BT, Aronson WJ, Kane CJ, Terris MK, Amling CL, Cooperberg MR, Freedland SJ
• In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH Database.
  European urology focus 2016 Whitney CA, Howard LE, Posadas EM, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Freedland SJ
• Cost-effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate Cancer.
  Clinical genitourinary cancer 2016 Lobo JM, Trifiletti DM, Sturz VN, Dicker AP, Buerki C, Davicioni E, Cooperberg MR, Karnes RJ, Jenkins RB, Den RB, Showalter TN
• Race does not predict the development of metastases in men with nonmetastatic castration-resistant prostate cancer.
  Cancer 2016 Whitney CA, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Freedland SJ
• Targeted PET imaging for prostate-specific membrane antigen in prostate cancer.
  Future oncology (London, England) 2016 Hope TA, Aggarwal RR, Westphalen AC, Cooperberg MR, Greene KL
• Validity of the Cancer of the Prostate Risk Assessment Score Derived From Targeted Biopsy: Modeling Evidence From Ultrasound Lesion-Directed Biopsy.
  Clinical genitourinary cancer 2016 Leapman MS, Ameli N, Shinohara K, Nguyen HG, Meng MV, Cooperberg MR, Carroll PR
• An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care.
  Urology 2016 Crawford ED, Rosenberg MT, Partin AW, Cooperberg MR, Maccini M, Loeb S, Pettaway CA, Shore ND, Arangua P, Hoenemeyer J, Leveridge M, Leapman M, Pinto P, Thompson IM, Carroll P, Eastham J, Gomella L, …
• Prostate cancer: Why the prostate arm of the PLCO trial failed and what it has taught us.
  Nature reviews. Urology 2016 Cooperberg MR
• Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?
  Prostate cancer and prostatic diseases 2016 Howard LE, De Hoedt AM, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Divers CH, Valderrama A, Freedland SJ
• Preoperative Frailty Is Associated With Discharge to Skilled or Assisted Living Facilities After Urologic Procedures of Varying Complexity.
  Urology 2016 Suskind AM, Jin C, Cooperberg MR, Finlayson E, Boscardin WJ, Sen S, Walter LC
• Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies.
  JAMA oncology 2016 Roth JA, Gulati R, Gore JL, Cooperberg MR, Etzioni R
• Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy.
  The Journal of urology 2016 Leapman MS, Freedland SJ, Aronson WJ, Kane CJ, Terris MK, Walker K, Amling CL, Carroll PR, Cooperberg MR
• Predictors of Time to Metastasis in Castration-resistant Prostate Cancer.
  Urology 2016 Moreira DM, Howard LE, Sourbeer KN, Amarasekara HS, Chow LC, Cockrell DC, Hanyok BT, Aronson WJ, Kane CJ, Terris MK, Amling CL, Cooperberg MR, Liede A, Freedland SJ
• Quantified Clinical Risk Change as an End Point During Prostate Cancer Active Surveillance.
  European urology 2016 Leapman MS, Ameli N, Cooperberg MR, Chu C, Hussein A, Shinohara K, Carroll PR
• Clinical Utility of Biomarkers in Localized Prostate Cancer.
  Current oncology reports 2016 Leapman MS, Nguyen HG, Cooperberg MR
• Asia prostate cancer study (A-CaP Study) launch symposium.
  Prostate international 2016 Akaza H, Hirao Y, Kim CS, Oya M, Ozono S, Ye D, Cooperberg M, Hinotsu S, Lee JY, Zhu G, Namiki M, Horie S, Chung BH, Chen CH, Fai NC, Hakim L, Chiong E, Letran J, Umbas R, Suzuki K, Nishimura K, Ong …
• Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens.
  The Journal of molecular diagnostics : JMD 2016 Knudsen BS, Kim HL, Erho N, Shin H, Alshalalfa M, Lam LLC, Tenggara I, Chadwich K, Van Der Kwast T, Fleshner N, Davicioni E, Carroll PR, Cooperberg MR, Chan JM, Simko JP
• When to Start Prostate Cancer Screening and When to Stop: Insights from Göteborg.
  The Journal of urology 2016 Cooperberg M
• Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Chen RC, Rumble RB, Loblaw DA, Finelli A, Ehdaie B, Cooperberg MR, Morgan SC, Tyldesley S, Haluschak JJ, Tan W, Justman S, Jain S
• Validation of a bone scan positivity risk table in non-metastatic castration-resistant prostate cancer.
  BJU international 2016 Freedland SJ, Howard LE, Hanyok BT, Kadiyala VK, Kuang JY, Whitney CA, Wilks FR, Kane CJ, Terris MK, Amling CL, Cooperberg MR, Aronson WJ, Moreira DM
• Words of Wisdom. Re: Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.
  European urology 2016 Tasian GE, Cooperberg MR
• Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016 Allott EH, Howard LE, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ
• Variation in prostate cancer treatment associated with population density of the county of residence.
  Prostate cancer and prostatic diseases 2016 Cary C, Odisho AY, Cooperberg MR
• Impact of frailty on complications in patients undergoing common urological procedures: a study from the American College of Surgeons National Surgical Quality Improvement database.
  BJU international 2016 Suskind AM, Walter LC, Jin C, Boscardin J, Sen S, Cooperberg MR, Finlayson E
• Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score.
  Urology 2015 Brand TC, Zhang N, Crager MR, Maddala T, Dee A, Sesterhenn IA, Simko JP, Cooperberg MR, Srivastava S, Rosner IL, Chan JM, Febbo PG, Carroll PR, Cullen J, Lawrence HJ
• Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database.
  International journal of urology : official journal of the Japanese Urological Association 2015 McGinley KF, Sun X, Howard LE, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ
• Treatment Trends for Prostate Cancer--Reply.
  JAMA 2015 Cooperberg MR, Carroll PR
• Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database.
  Cancer 2015 Hanyok BT, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Posadas EM, Freedland SJ
• Reply from Authors re: Julia Verne, Luke Hounsome, Roger Kockelbergh, Jem Rashbass. Improving Outcomes from Prostate Cancer: Unlocking the Treasure Trove of Information in Cancer Registries. Eur Urol 2016;69:1013-4.
  European urology 2015 Gandaglia G, Bray F, Cooperberg MR, Karnes RJ, Leveridge MJ, Moretti K, Murphy DG, Penson DF, Miller DC
• Do all men with pathological Gleason score 8-10 prostate cancer have poor outcomes? Results from the SEARCH database.
  BJU international 2015 Fischer S, Lin D, Simon RM, Howard LE, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ, Vidal AC
• Does larger tumor volume explain the higher prostate specific antigen levels in black men with prostate cancer--Results from the SEARCH database.
  Cancer epidemiology 2015 Klaassen Z, Howard L, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Kane CJ, Freedland SJ
• The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples.
  The Journal of urology 2015 O'Neil B, Koyama T, Alvarez J, Conwill RM, Albertsen PC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hoffman KE, Hoffman RM, Kaplan SH, Stanford JL, Stroup AM, Paddock LE, Wu XC, Stephenson …
• Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort.
  The Journal of urology 2015 Newcomb LF, Thompson IM, Boyer HD, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Ellis WJ, Fazli L, Feng Z, Gleave ME, Kunju P, Lance RS, McKenney JK, Meng MV, Nicolas MM, Sanda MG, Simko J, So A, …
• Rebuttal to Drs. Markovina and Michalski.
  Brachytherapy 2015 Hussein AA, Cooperberg MR
• Point: Surgery is the most cost-effective option for prostate cancer needing treatment.
  Brachytherapy 2015 Hussein AA, Cooperberg MR
• Trends in Management for Patients With Localized Prostate Cancer, 1990-2013.
  JAMA 2015 Cooperberg MR, Carroll PR
• Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: is adjuvant radiation warranted?
  BJU international 2015 Simon RM, Howard LE, Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Vidal AC
• Positive surgical margins in radical prostatectomy patients do not predict long-term oncological outcomes: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort.
  BJU international 2015 Mithal P, Howard LE, Aronson WJ, Terris MK, Cooperberg MR, Kane CJ, Amling C, Freedland SJ
• Prostate Cancer Registries: Current Status and Future Directions.
  European urology 2015 Gandaglia G, Bray F, Cooperberg MR, Karnes RJ, Leveridge MJ, Moretti K, Murphy DG, Penson DF, Miller DC
• Editorial Comment.
  Urology 2015 Cooperberg MR
• Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter?
  BJU international 2015 Hsu CC, Paciorek AT, Cooperberg MR, Roach M, Hsu IC, Carroll PR
• Predicting bone scan positivity in non-metastatic castration-resistant prostate cancer.
  Prostate cancer and prostatic diseases 2015 Moreira DM, Howard LE, Sourbeer KN, Amarasekara HS, Chow LC, Cockrell DC, Hanyok BT, Pratson CL, Aronson WJ, Kane CJ, Terris MK, Amling CL, Cooperberg MR, Liede A, Freedland SJ
• Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives.
  European urology 2015 Bayne CE, Williams SB, Cooperberg MR, Gleave ME, Graefen M, Montorsi F, Novara G, Smaldone MC, Sooriakumaran P, Wiklund PN, Chapin BF
• Agent Orange and long-term outcomes after radical prostatectomy.
  Urologic oncology 2015 Ovadia AE, Terris MK, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ, Abern MR
• Trans-Pacific variation in outcomes for men treated with primary androgen-deprivation therapy (ADT) for prostate cancer.
  BJU international 2015 Cooperberg MR, Hinotsu S, Namiki M, Carroll PR, Akaza H
• Genomic Predictors of Outcome in Prostate Cancer.
  European urology 2015 Boström PJ, Bjartell AS, Catto JW, Eggener SE, Lilja H, Loeb S, Schalken J, Schlomm T, Cooperberg MR
• Smoking is a predictor of adverse pathological features at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database.
  International journal of urology : official journal of the Japanese Urological Association 2015 Zapata DF, Howard LE, Aronson WJ, Kane CJ, Terris MK, Amling CL, Cooperberg MR, Freedland SJ
• Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study.
  European journal of cancer (Oxford, England : 1990) 2015 Garcia-Albeniz X, Chan JM, Paciorek A, Logan RW, Kenfield SA, Cooperberg MR, Carroll PR, Hernán MA
• Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
  International journal of urology : official journal of the Japanese Urological Association 2015 Mithal P, Howard LE, Aronson WJ, Kane CJ, Cooperberg MR, Terris MK, Amling CL, Freedland SJ
• Updated Survey of Social Media Use by Members of the American Urological Association.
  Urology practice 2015 Loeb S, Bayne CE, Frey C, Davies BJ, Averch TD, Woo HH, Stork B, Cooperberg MR, Griebling TL, Eggener SE, American Urological Association Social Media Work Group
• Nationally representative trends and geographic variation in treatment of localized prostate cancer: the Urologic Diseases in America project.
  Prostate cancer and prostatic diseases 2015 Cary KC, Punnen S, Odisho AY, Litwin MS, Saigal CS, Cooperberg MR, NIDDK Urologic Diseases in America Project
• Impact of age on quality-of-life outcomes after treatment for localized prostate cancer.
  European urology 2015 Hampson LA, Cowan JE, Zhao S, Carroll PR, Cooperberg MR
• Proton therapy websites: information anarchy creates confusion.
  BJU international 2015 Basto M, Cooperberg MR, Murphy DG
• Current Use of Imaging after Primary Treatment of Prostate Cancer.
  The Journal of urology 2015 Hussein AA, Punnen S, Zhao S, Cowan JE, Leapman M, Tran TC, Washington SL, Truesdale MD, Carroll PR, Cooperberg MR
• Who bears the greatest burden of aggressive treatment of indolent prostate cancer?
  The American journal of medicine 2015 Mahal BA, Cooperberg MR, Aizer AA, Ziehr DR, Hyatt AS, Choueiri TK, Hu JC, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Orio PF, Trinh QD, Nguyen PL
• Diagnostic associations of gene expression signatures in prostate cancer tissue.
  Current opinion in urology 2015 Nguyen HG, Welty CJ, Cooperberg MR
• Long-term active surveillance for prostate cancer: answers and questions.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Cooperberg MR
• Is clinical stage T2c prostate cancer an intermediate- or high-risk disease?
  Cancer 2014 Klaassen Z, Singh AA, Howard LE, Feng Z, Trock B, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Kane CJ, Partin A, Han M, Freedland SJ
• Practice patterns and predictors of followup imaging after a negative bone scan in men with castration resistant prostate cancer: results from the SEARCH database.
  The Journal of urology 2014 Sourbeer KN, Howard LE, Moreira DM, Amarasekara HS, Chow LD, Cockrell DC, Hanyok BT, Pratson CL, Kane CJ, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Hernandez RK, Freedland SJ
• Sustainable Measurement of Response Shift in Prostate Cancer Patients: Adjusting Health Related Quality of Life with the Then-Test.
  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2014 Ten Ham RM, Wilson LS, Broering JM, Cooperberg MR, Carroll P
• Overdetection of recurrence after radical prostatectomy: estimates based on patient and tumor characteristics.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Xia J, Trock BJ, Gulati R, Mallinger L, Cooperberg MR, Carroll PR, Carter HB, Etzioni R
• Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH database.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014 Allott EH, Howard LE, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Freedland SJ
• Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer.
  The Journal of urology 2014 Welty CJ, Cowan JE, Nguyen H, Shinohara K, Perez N, Greene KL, Chan JM, Meng MV, Simko JP, Cooperberg MR, Carroll PR
• Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
  European urology 2014 Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR
• Progress in management of low-risk prostate cancer: how registries may change the world.
  European urology 2014 Cooperberg MR
• A simple schema for informed decision making about prostate cancer screening.
  Annals of internal medicine 2014 Vickers AJ, Edwards K, Cooperberg MR, Mushlin AI
• The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research.
  European urology 2014 Resnick MJ, Barocas DA, Morgans AK, Phillips SE, Koyama T, Albertsen PC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hoffman KE, Hoffman RM, Kaplan SH, McCollum D, Paddock LE, Stanford JL, …
• European Urology: serving our readership through systematic peer review, use of reporting standards, and encouragement of postpublication review.
  European urology 2014 Catto JW, Cooperberg MR, Cornu JN, Gratzke C, Novara G, Shariat SF, Vickers A
• Reply to Yuri Tolkach, Markus Kuczyk, Florian Imkamp's letter to the editor re: Eric A. Klein, Matthew R. Cooperberg, Cristina Magi-Galluzzi, et al. A 17-gene assay to predict prostate cancer aggressiveness in the context of gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur urol 2014;66:550-60.
  European urology 2014 Klein EA, Cooperberg MR, Carroll PR
• Expected population impacts of discontinued prostate-specific antigen screening.
  Cancer 2014 Gulati R, Tsodikov A, Etzioni R, Hunter-Merrill RA, Gore JL, Mariotto AB, Cooperberg MR
• European Association of Urology (@Uroweb) recommendations on the appropriate use of social media.
  European urology 2014 Rouprêt M, Morgan TM, Bostrom PJ, Cooperberg MR, Kutikov A, Linton KD, Palou J, Martínez-Piñeiro L, van der Poel H, Wijburg C, Winterbottom A, Woo HH, Wirth MP, Catto JW
• Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort.
  European urology 2014 Cooperberg MR, Davicioni E, Crisan A, Jenkins RB, Ghadessi M, Karnes RJ
• Implications of the new AUA guidelines on prostate cancer detection in the U.S.
  Current urology reports 2014 Cooperberg MR
• Seventh Joint Meeting of K-J-CaP and CaPSURE: extending the global initiative to improve prostate cancer management.
  Prostate international 2014 Akaza H, Kim CS, Carroll P, Choi IY, Chung BH, Cooperberg MR, Hirao Y, Hinotsu S, Horie S, Lee JY, Namiki M, Ng CF, Onozawa M, Ozono S, Ueno S, Umbas R, Ye D, Zhu G
• miR-19, miR-345, miR-519c-5p serum levels predict adverse pathology in prostate cancer patients eligible for active surveillance.
  PloS one 2014 Wang SY, Shiboski S, Belair CD, Cooperberg MR, Simko JP, Stoppler H, Cowan J, Carroll PR, Blelloch R
• Use of social media in urology: data from the American Urological Association (AUA).
  BJU international 2014 Loeb S, Bayne CE, Frey C, Davies BJ, Averch TD, Woo HH, Stork B, Cooperberg MR, Eggener SE, American Urological Association Social Media Work Group
• A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
  European urology 2014 Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko JP, Falzarano SM, Maddala T, Chan JM, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, Febbo PG, Shak S, …
• Updated trends in imaging use in men diagnosed with prostate cancer.
  Prostate cancer and prostatic diseases 2014 Porten SP, Smith A, Odisho AY, Litwin MS, Saigal CS, Carroll PR, Cooperberg MR, Urologic Disease of America Project
• Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
  BJU international 2014 Allott EH, Howard LE, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Freedland SJ
• Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancer.
  Current opinion in urology 2014 Welty CJ, Cooperberg MR, Carroll PR
• Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.
  European urology 2014 Jalloh M, Myers F, Cowan JE, Carroll PR, Cooperberg MR
• Editorial comment.
  The Journal of urology 2014 Cooperberg MR
• Prostate cancer: a new look at prostate cancer treatment complications.
  Nature reviews. Clinical oncology 2014 Cooperberg MR
• The impact of pathologic staging on the long-term oncologic outcomes of patients with clinically high-risk prostate cancer.
  Cancer 2014 Abern MR, Terris MK, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ
• Early detection of prostate cancer.
  The Urologic clinics of North America 2014 Loeb S, Cooperberg MR
• A risk-adjusted definition of biochemical recurrence after radical prostatectomy.
  Prostate cancer and prostatic diseases 2014 Morgan TM, Meng MV, Cooperberg MR, Cowan JE, Weinberg V, Carroll PR, Lin DW
• Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer.
  BJU international 2014 Wang SY, Cowan JE, Cary KC, Chan JM, Carroll PR, Cooperberg MR
• Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment.
  Cancer 2014 Resnick MJ, Barocas DA, Morgans AK, Phillips SE, Chen VW, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hoffman KE, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Koyama T, Penson DF
• The Melbourne Consensus Statement on the early detection of prostate cancer.
  BJU international 2014 Murphy DG, Ahlering T, Catalona WJ, Crowe H, Crowe J, Clarke N, Cooperberg M, Gillatt D, Gleave M, Loeb S, Roobol M, Sartor O, Pickles T, Wootten A, Walsh PC, Costello AJ
• Novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: a systematic review.
  European urology 2014 van den Bergh RC, Ahmed HU, Bangma CH, Cooperberg MR, Villers A, Parker CC
• Predicting bone scan positivity after biochemical recurrence following radical prostatectomy in both hormone-naive men and patients receiving androgen-deprivation therapy: results from the SEARCH database.
  Prostate cancer and prostatic diseases 2014 Moreira DM, Cooperberg MR, Howard LE, Aronson WJ, Kane CJ, Terris MK, Amling CL, Kuchibhatla M, Freedland SJ
• Implementation of PSA-based active surveillance in prostate cancer.
  Biomarkers in medicine 2014 Jalloh M, Cooperberg MR
• Impact of national guidelines on brachytherapy monotherapy practice patterns for prostate cancer.
  Cancer 2013 Tseng YD, Paciorek AT, Martin NE, D'Amico AV, Cooperberg MR, Nguyen PL
• Biomarkers in prostate cancer surveillance and screening: past, present, and future.
  Therapeutic advances in urology 2013 Cary KC, Cooperberg MR
• Impact of androgen deprivation therapy on mental and emotional well-being in men with prostate cancer: analysis from the CaPSURE™ registry.
  The Journal of urology 2013 Cary KC, Singla N, Cowan JE, Carroll PR, Cooperberg MR
• Temporal trends and predictors of salvage cancer treatment after failure following radical prostatectomy or radiation therapy: an analysis from the CaPSURE registry.
  Cancer 2013 Cary KC, Paciorek A, Fuldeore MJ, Carroll PR, Cooperberg MR
• Long-term follow-up of International Prostate Symptom Score (IPSS) in men following prostate brachytherapy.
  World journal of urology 2013 Li X, Fang D, Cooperberg MR, Whitson JM, Lue TF, Zhou L, Shinohara K
• Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH database.
  Cancer 2013 Moreira DM, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Boffetta P, Freedland SJ
• Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database.
  Prostate cancer and prostatic diseases 2013 Allott EH, Abern MR, Gerber L, Keto CJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Moorman PG, Freedland SJ
• Reply to A. Azad et al.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Cooperberg MR, Cowan JE, Carroll PR
• Re-examining racial disparities in prostate cancer outcomes.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Cooperberg MR
• Divorcing diagnosis from treatment: contemporary management of low-risk prostate cancer.
  Korean journal of urology 2013 Glass AS, Punnen S, Cooperberg MR
• A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer.
  BJU international 2013 Punnen S, Cowan JE, Dunn LB, Shumay DM, Carroll PR, Cooperberg MR
• The epidemiology of high-risk prostate cancer.
  Current opinion in urology 2013 Punnen S, Cooperberg MR
• Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study.
  Journal of comparative effectiveness research 2013 Barocas DA, Chen V, Cooperberg M, Goodman M, Graff JJ, Greenfield S, Hamilton A, Hoffman K, Kaplan S, Koyama T, Morgans A, Paddock LE, Phillips S, Resnick MJ, Stroup A, Wu XC, Penson DF
• Expanding utilization of intensity-modulated radiotherapy for prostate cancer: soaring costs, dubious benefits: comment on "Comparative effectiveness of intensity-modulated radiotherapy and conventional conformal radiotherapy in the treatment of prostate cancer after radical prostatectomy".
  JAMA internal medicine 2013 Cooperberg MR
• Risk-based prostate cancer screening: who and how?
  Current urology reports 2013 Glass AS, Cary KC, Cooperberg MR
• Words of wisdom. Re: Quality-of-life effects of prostate-specific antigen screening.
  European urology 2013 Cooperberg MR
• Sixth joint meeting of J-CaP and CaPSURE--a multinational perspective on prostate cancer management and patient outcomes.
  Japanese journal of clinical oncology 2013 Akaza H, Hinotsu S, Cooperberg MR, Chung BH, Youl Lee J, Umbas R, Tsukamoto T, Namiki M, Carroll P
• Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA era.
  Urology 2013 Glass AS, Cowan JE, Fuldeore MJ, Cooperberg MR, Carroll PR, Kenfield SA, Greene KL
• Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature.
  European urology 2013 Punnen S, Cooperberg MR, D'Amico AV, Karakiewicz PI, Moul JW, Scher HI, Schlomm T, Freedland SJ
• Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy.
  European urology 2013 Punnen S, Freedland SJ, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Carroll PR, Cooperberg MR
• Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer Screening.
  Medical care 2013 Etzioni R, Gulati R, Cooperberg MR, Penson DM, Weiss NS, Thompson IM
• How does robot-assisted radical prostatectomy (RARP) compare with open surgery in men with high-risk prostate cancer?
  BJU international 2013 Punnen S, Meng MV, Cooperberg MR, Greene KL, Cowan JE, Carroll PR
• Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Cooperberg MR, Simko JP, Cowan JE, Reid JE, Djalilvand A, Bhatnagar S, Gutin A, Lanchbury JS, Swanson GP, Stone S, Carroll PR
• Proximal bulbar periurethral abscess.
  International braz j urol : official journal of the Brazilian Society of Urology 2013 Blaschko SD, Weiss DA, Odisho AY, Greene KL, Cooperberg MR
• Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis.
  BJU international 2012 Cooperberg MR, Ramakrishna NR, Duff SB, Hughes KE, Sadownik S, Smith JA, Tewari AK
• Role of active surveillance in the management of localized prostate cancer.
  Journal of the National Cancer Institute. Monographs 2012 Glass AS, Cooperberg MR, Meng MV, Carroll PR
• Factors associated with treatment received by men diagnosed with prostate cancer in queensland, australia.
  BJU international 2012 Cooperberg MR
• Prostate cancer mortality following active surveillance versus immediate radical prostatectomy.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Xia J, Trock BJ, Cooperberg MR, Gulati R, Zeliadt SB, Gore JL, Lin DW, Carroll PR, Carter HB, Etzioni R
• High-risk nonmuscle invasive bladder cancer: definition and epidemiology.
  Current opinion in urology 2012 Porten SP, Cooperberg MR
• Reply to Jai Prakash, Apul Goel and Manish Garg's Letter to the Editor re: Anobel Y. Odisho, Anna B. Berry, Ardalan E. Ahmad, Matthew R. Cooperberg, Peter R. Carroll, Badrinath R. Konety. Reflex ImmunoCyt Testing for the Diagnosis of Bladder Cancer in Patients with Atypical Urine Cytology. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.019.
  European urology 2012 Odisho AY, Berry AB, Ahmad AE, Cooperberg MR, Carroll PR, Konety BR
• Prostate cancer: new types of radiotherapy improve cancer outcome but at what cost?
  Nature reviews. Urology 2012 Murphy DG, Williams S, Cooperberg MR
• Early detection of prostate cancer: more information, more clarity.
  European urology 2012 Glass AS, Cooperberg MR, Carroll PR
• Editorial comment.
  Urology 2012 Cooperberg MR, Chan JM
• Will biomarkers save prostate cancer screening?
  European urology 2012 Cooperberg MR
• Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram.
  Prostate cancer and prostatic diseases 2012 Kutikov A, Cooperberg MR, Paciorek AT, Uzzo RG, Carroll PR, Boorjian SA
• Active surveillance for prostate cancer: a systematic review of the literature.
  European urology 2012 Dall'Era MA, Albertsen PC, Bangma C, Carroll PR, Carter HB, Cooperberg MR, Freedland SJ, Klotz LH, Parker C, Soloway MS
• The quantitative Gleason score improves prostate cancer risk assessment.
  Cancer 2012 Reese AC, Cowan JE, Brajtbord JS, Harris CR, Carroll PR, Cooperberg MR
• Urological cancer: For localized prostate cancer, does technology equal progress?
  Nature reviews. Clinical oncology 2012 Cooperberg MR
• Reflex ImmunoCyt testing for the diagnosis of bladder cancer in patients with atypical urine cytology.
  European urology 2012 Odisho AY, Berry AB, Ahmad AE, Cooperberg MR, Carroll PR, Konety BR
• To predict the future, consider the present as well as the past.
  European urology 2012 Cooperberg MR
• Thwarting high-risk prostate cancer: the right treatments for the right patients.
  European urology 2012 Cooperberg MR
• Proton beam therapy and treatment for localized prostate cancer: if you build it, they will come.
  Archives of internal medicine 2012 Aaronson DS, Odisho AY, Hills N, Cress R, Carroll PR, Dudley RA, Cooperberg MR
• Fifth Joint Meeting of J-CaP and CaPSURE: advancing the global understanding of prostate cancer and its management.
  Japanese journal of clinical oncology 2012 Akaza H, Carroll P, Cooperberg MR, Hinotsu S
• Outcomes for radical prostatectomy: is it the singer, the song, or both?
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Cooperberg MR, Odisho AY, Carroll PR
• Adverse effects of androgen deprivation and the limits of national tumor registries.
  European urology 2011 Cooperberg MR
• PSA screening: determinants of primary-care physician practice patterns.
  Prostate cancer and prostatic diseases 2011 Tasian GE, Cooperberg MR, Potter MB, Cowan JE, Greene KL, Carroll PR, Chan JM
• High-risk prostate cancer: treat the prostate.
  Lancet (London, England) 2011 Cooperberg MR
• Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer.
  Prostate cancer and prostatic diseases 2011 Wu AK, Reese AC, Cooperberg MR, Sadetsky N, Shinohara K
• External-beam radiation therapy should be given with androgen deprivation treatment for intermediate-risk prostate cancer: new confirmatory evidence.
  Asian journal of andrology 2011 Cooperberg MR
• Among potent men post radical prostatectomy, does the need for phosphodiesterase inhibitors have an impact on sexual bother scores?
  BJU international 2011 Punnen S, Cooperberg MR, Sadetsky N, Carroll PR
• Words of wisdom. Re: Radical prostatectomy versus watchful waiting in early prostate cancer.
  European urology 2011 Cooperberg MR
• Prediction of erectile function following treatment for prostate cancer.
  JAMA 2011 Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsky N, Saigal CS, Litwin MS, Klein E, Kibel AS, Hamstra DA, Pisters LL, Kuban DA, Kaplan ID, Wood DP, Ciezki …
• Androgen deprivation therapy and cardiovascular risk.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Punnen S, Cooperberg MR, Sadetsky N, Carroll PR
• Active surveillance for prostate cancer: progress and promise.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Cooperberg MR, Carroll PR, Klotz L
• Treatment trends for stage I renal cell carcinoma.
  The Journal of urology 2011 Cooperberg MR, Mallin K, Kane CJ, Carroll PR
• The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy.
  Cancer 2011 Cooperberg MR, Hilton JF, Carroll PR
• Editorial comment.
  Urology 2011 Cooperberg MR
• Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Porten SP, Whitson JM, Cowan JE, Cooperberg MR, Shinohara K, Perez N, Greene KL, Meng MV, Carroll PR
• Factors associated with downgrading in patients with high grade prostate cancer.
  Urologic oncology 2011 Whitson JM, Porten SP, Cowan JE, Simko JP, Cooperberg MR, Carroll PR
• The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer.
  The Journal of urology 2011 Whitson JM, Porten SP, Hilton JF, Cowan JE, Perez N, Cooperberg MR, Greene KL, Meng MV, Simko JP, Shinohara K, Carroll PR
• Impact of androgen deprivation on physical well-being in patients with prostate cancer: analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry.
  Cancer 2011 Sadetsky N, Greene K, Cooperberg MR, Hubbard A, Carroll PR, Satariano W
• The example of CaPSURE: lessons learned from a national disease registry.
  World journal of urology 2011 Porten SP, Cooperberg MR, Konety BR, Carroll PR
• Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes?
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Carroll PR, Whitson JM, Cooperberg MR
• Impact of age at diagnosis on prostate cancer treatment and survival.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Bechis SK, Carroll PR, Cooperberg MR
• Outcomes of active surveillance for men with intermediate-risk prostate cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Cooperberg MR, Cowan JE, Hilton JF, Reese AC, Zaid HB, Porten SP, Shinohara K, Meng MV, Greene KL, Carroll PR
• Inaccuracies in assignment of clinical stage for localized prostate cancer.
  Cancer 2010 Reese AC, Sadetsky N, Carroll PR, Cooperberg MR
• Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer.
  Cancer 2010 Cooperberg MR, Vickers AJ, Broering JM, Carroll PR
• Disproportionate presentation of high risk prostate cancer in a safety net health system.
  The Journal of urology 2010 Porten SP, Richardson DA, Odisho AY, McAninch JW, Carroll PR, Cooperberg MR
• Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
  Urologic oncology 2010 Tasian GE, Cooperberg MR, Cowan JE, Keyashian K, Greene KL, Daniels NA, Carroll PR, Chan JM
• Gender differences in subcutaneous and perirenal fat distribution.
  Surgical and radiologic anatomy : SRA 2010 Eisner BH, Zargooshi J, Berger AD, Cooperberg MR, Doyle SM, Sheth S, Stoller ML
• Adequacy of a single 24-hour urine collection for metabolic evaluation of recurrent nephrolithiasis.
  The Journal of urology 2010 Castle SM, Cooperberg MR, Sadetsky N, Eisner BH, Stoller ML
• Electronic patient self-assessment and management (SAM): a novel framework for cancer survivorship.
  BMC medical informatics and decision making 2010 Vickers AJ, Salz T, Basch E, Cooperberg MR, Carroll PR, Tighe F, Eastham J, Rosen RC
• Specialist visits (urologist, radiation oncologist, medical oncologist) are strongly associated with treatment received for prostate cancer in the USA.
  Evidence-based medicine 2010 Cooperberg MR
• Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease.
  The Journal of urology 2010 Reese AC, Cooperberg MR, Carroll PR
• Urologist density and county-level urologic cancer mortality.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Odisho AY, Cooperberg MR, Fradet V, Ahmad AE, Carroll PR
• Changes in specific domains of sexual function and sexual bother after radical prostatectomy.
  BJU international 2010 Le JD, Cooperberg MR, Sadetsky N, Hittelman AB, Meng MV, Cowan JE, Latini DM, Carroll PR, CaPSURE Investigators
• Time trends and local variation in primary treatment of localized prostate cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Cooperberg MR, Broering JM, Carroll PR
• In vivo tumor grading of prostate cancer using quantitative 111In-capromab pendetide SPECT/CT.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009 Seo Y, Aparici CM, Cooperberg MR, Konety BR, Hawkins RA
• The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized disease.
  BJU international 2009 Porten SP, Cooperberg MR, Carroll PR
• Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Cooperberg MR, Hinotsu S, Namiki M, Ito K, Broering J, Carroll PR, Akaza H
• Fourth joint meeting of the American Urological Association and the Japanese Urological Association Specialty Society program at the 104th annual meeting of the American Urological Association at Chicago 2009.
  International journal of urology : official journal of the Japanese Urological Association 2009 Cooperberg MR, Hinotsu S, Chancellor MB, Homma Y, Nelson PS, Matsuyama H, Menon M, Kucuk O, Hara I, Egawa S, Uzzo RG, Kanayama HO, Okuyama A, Akaza H
• Prostate-cancer screening.
  The New England journal of medicine 2009 Cooperberg MR, Carroll PR
• Candidate quality of care indicators for localized bladder cancer.
  Urologic oncology 2009 Cooperberg MR, Porter MP, Konety BR
• Defining high quality health care.
  Urologic oncology 2009 Cooperberg MR, Birkmeyer JD, Litwin MS
• Adequacy of lymphadenectomy among men undergoing robot-assisted laparoscopic radical prostatectomy.
  BJU international 2009 Cooperberg MR, Kane CJ, Cowan JE, Carroll PR
• Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis.
  Journal of the National Cancer Institute 2009 Cooperberg MR, Broering JM, Carroll PR
• Management of localized prostate cancer in men over 65 years.
  Current opinion in urology 2009 Cooperberg MR, Konety BR
• Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy.
  European urology 2009 Eisenberg ML, Davies BJ, Cooperberg MR, Cowan JE, Carroll PR
• Patients with primary hyperparathyroidism--why do some form stones?
  The Journal of urology 2009 Berger AD, Wu W, Eisner BH, Cooperberg MR, Duh QY, Stoller ML
• Are age-based criteria the best way to determine eligibility for prostate cancer screening?
  Annals of internal medicine 2009 Konety BR, Cooperberg MR, Carroll PR
• Geographic distribution of urologists throughout the United States using a county level approach.
  The Journal of urology 2008 Odisho AY, Fradet V, Cooperberg MR, Ahmad AE, Carroll PR
• Prostate cancer risk assessment: choosing the sharpest tool in the shed.
  Cancer 2008 Cooperberg MR
• Health related quality of life in patients treated with multimodal therapy for prostate cancer.
  The Journal of urology 2008 Wu AK, Cooperberg MR, Sadetsky N, Carroll PR
• Renal cell cancer stage migration: analysis of the National Cancer Data Base.
  Cancer 2008 Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR
• Active surveillance for the management of prostate cancer in a contemporary cohort.
  Cancer 2008 Dall'Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane CJ, Perez N, Master VA, Carroll PR
• Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004.
  The Journal of urology 2008 Cooperberg MR, Mallin K, Ritchey J, Villalta JD, Carroll PR, Kane CJ
• Active surveillance for early-stage prostate cancer: review of the current literature.
  Cancer 2008 Dall'Era MA, Cooperberg MR, Chan JM, Davies BJ, Albertsen PC, Klotz LH, Warlick CA, Holmberg L, Bailey DE, Wallace ME, Kantoff PW, Carroll PR
• High-risk prostate cancer in the United States, 1990-2007.
  World journal of urology 2008 Cooperberg MR, Cowan J, Broering JM, Carroll PR
• Oral calcium supplementation associated with decreased likelihood of nephrolithiasis prior to surgery for hyperparathyroidism.
  International journal of urology : official journal of the Japanese Urological Association 2007 Cooperberg MR, Duh QY, Stackhouse GB, Stoller ML
• Urinary citrate levels do not correlate with urinary pH in patients with urinary stone formation.
  Urology 2007 Whitson JM, Cooperberg MR, Stackhouse GB, Stoller ML
• Trends in regionalization of inpatient care for urological malignancies, 1988 to 2002.
  The Journal of urology 2007 Cooperberg MR, Modak S, Konety BR
• Urethral reconstruction for traumatic posterior urethral disruption: outcomes of a 25-year experience.
  The Journal of urology 2007 Cooperberg MR, McAninch JW, Alsikafi NF, Elliott SP
• Contemporary trends in low risk prostate cancer: risk assessment and treatment.
  The Journal of urology 2007 Cooperberg MR, Broering JM, Kantoff PW, Carroll PR
• Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy.
  Cancer 2006 Cooperberg MR, Freedland SJ, Pasta DJ, Elkin EP, Presti JC, Amling CL, Terris MK, Aronson WJ, Kane CJ, Carroll PR
• Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE.
  Cancer 2006 Latini DM, Elkin EP, Cooperberg MR, Sadetsky N, Duchane J, Carroll PR
• The changing face of prostate cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005 Cooperberg MR, Moul JW, Carroll PR
• Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
  Urology 2005 Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, Pasta DJ, Chan JM, Anast JW, Carroll PR, Kane CJ
• Who is the average patient presenting with prostate cancer?
  Urology 2005 Greene KL, Cowan JE, Cooperberg MR, Meng MV, DuChane J, Carroll PR, Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) Investigators
• Variability in testis biopsy interpretation: implications for male infertility care in the era of intracytoplasmic sperm injection.
  Fertility and sterility 2005 Cooperberg MR, Chi T, Jad A, Cha I, Turek PJ
• The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy.
  The Journal of urology 2005 Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, Carroll PR
• Laparoscopic management of peripelvic renal cysts: University of California, San Francisco, experience and review of literature.
  Urology 2005 Camargo AH, Cooperberg MR, Ershoff BD, Rubenstein JN, Meng MV, Stoller ML
• Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
  The Journal of urology 2005 Mitchell JA, Cooperberg MR, Elkin EP, Lubeck DP, Mehta SS, Kane CJ, Carroll PR
• The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE).
  The Journal of urology 2005 Anast JW, Sadetsky N, Pasta DJ, Bassett WW, Latini D, DuChane J, Chan JM, Cooperberg MR, Carroll PR, Kane CJ
• Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE.
  The Journal of urology 2005 Kane CJ, Bassett WW, Sadetsky N, Silva S, Wallace K, Pasta DJ, Cooperberg MR, Chan JM, Carroll PR
• Percutaneous neuromodulation.
  The Urologic clinics of North America 2005 Cooperberg MR, Stoller ML
• Prostate cancer 2004: insights from national disease registries.
  Oncology (Williston Park, N.Y.) 2004 Cooperberg MR, Park S, Carroll PR
• Patterns of practice in the United States: insights from CaPSURE on prostate cancer management.
  Current urology reports 2004 Cooperberg MR, Broering JM, Latini DM, Litwin MS, Wallace KL, Carroll PR
• The changing face of low-risk prostate cancer: trends in clinical presentation and primary management.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004 Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR
• Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure).
  The Journal of urology 2004 Greene KL, Meng MV, Elkin EP, Cooperberg MR, Pasta DJ, Kattan MW, Wallace K, Carroll PR
• Radical retropubic prostatectomy frustrated by prior laparoscopic mesh herniorrhaphy.
  Surgery 2004 Cooperberg MR, Downs TM, Carroll PR
• The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.
  The Journal of urology 2004 Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, Carroll PR, CaPSURE Investigators
• Mapping tumor epitope space by direct selection of single-chain Fv antibody libraries on prostate cancer cells.
  Cancer research 2004 Liu B, Conrad F, Cooperberg MR, Kirpotin DB, Marks JD
• The evolving role of androgen deprivation therapy in the management of prostate cancer.
  Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2003 Cooperberg MR, Small EJ, D'Amico A, Carroll PR
• Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE).
  The Journal of urology 2003 Cooperberg MR, Lubeck DP, Mehta SS, Carroll PR, CaPSURE
• Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.
  The Journal of urology 2003 Harlan SR, Cooperberg MR, Elkin E, Lubeck DP, Meng M, Mehta SS, Carroll PR
• Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE.
  The Journal of urology 2003 Cooperberg M, Lubeck DP, Penson D, Mehta SS, Carroll PR, Kane CJ
• Health related quality of life significance of single pad urinary incontinence following radical prostatectomy.
  The Journal of urology 2003 Cooperberg MR, Master VA, Carroll PR
• National practice patterns and time trends in androgen ablation for localized prostate cancer.
  Journal of the National Cancer Institute 2003 Cooperberg MR, Grossfeld GD, Lubeck DP, Carroll PR
• How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE.
  Urology 2003 Cooperberg MR, Koppie TM, Lubeck DP, Ye J, Grossfeld GD, Mehta SS, Carroll PR, CaPSURE
• Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor.
  The Journal of urology 2002 Cooperberg MR, Lubeck DP, Grossfeld GD, Mehta SS, Carroll PR
• Ki-1 anaplastic large-cell lymphoma occurring at the site of ileocolonic anastomosis in a patient treated surgically for colonic adenocarcinoma: case report and review of the literature.
  Annals of diagnostic pathology 2001 Cooperberg MR, Fiedler PN
• Cystic pelvic pathology presenting as falsely elevated post-void residual urine measured by portable ultrasound bladder scanning: report of 3 cases and review of the literature.
  Urology 2000 Cooperberg MR, Chambers SK, Rutherford TJ, Foster HE
• Methods for Chemoprotection and Chemosensitization : MDR-1 For Chemoprotection Using Retroviruses to Modify Hematopoietic Cells and Cytosine Deaminase for Chemosensitization Using Adenoviral Vectors to Modify Epithelian Neoplastic Cells.
  Methods in molecular medicine 2000 Shrimdkandada S, Fu SQ, Yin LH, Guo XY, Nanakorn T, Peng XY, Dizon D, Lin D, Cooperberg M, Won JH, Deisseroth A
• Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.
  Blood 1998 Garcia-Sanchez F, Pizzorno G, Fu SQ, Nanakorn T, Krause DS, Liang J, Adams E, Leffert JJ, Yin LH, Cooperberg MR, Hanania E, Wang WL, Won JH, Peng XY, Cote R, Brown R, Burtness B, Giles R, Crystal R, …